Form 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
(Mark One)
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 28, 2009
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to .
Commission file number 1-5353
TELEFLEX INCORPORATED
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
23-1147939 |
(State or other jurisdiction of
|
|
(I.R.S. employer identification no.) |
incorporation or organization) |
|
|
|
|
|
155 South Limerick Road, Limerick, Pennsylvania
|
|
19468 |
(Address of principal executive offices)
|
|
(Zip Code) |
(610) 948-5100
(Registrants telephone number, including area code)
(None)
(Former Name, Former Address and Former Fiscal Year,
If Changed Since Last Report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes þ No o
Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer,
or a smaller reporting company. See the definitions of large accelerated filler, accelerated filer and smaller
reporting company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer þ
|
|
Accelerated filer o
|
|
Non-accelerated filer o
(Do not check if smaller reporting company)
|
|
Smaller reporting company o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Act).
Yes o No þ
On
July 17, 2009, 39,722,921 shares of the registrants common stock, $1.00 par value, were
outstanding.
TELEFLEX INCORPORATED
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED JUNE 28, 2009
TABLE OF CONTENTS
1
PART I FINANCIAL INFORMATION
Item 1. Financial Statements
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars and shares in thousands, except per share) |
|
|
Net revenues |
|
$ |
483,059 |
|
|
$ |
559,678 |
|
|
$ |
952,734 |
|
|
$ |
1,101,788 |
|
Materials, labor and other product costs |
|
|
277,048 |
|
|
|
325,362 |
|
|
|
550,599 |
|
|
|
654,033 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
206,011 |
|
|
|
234,316 |
|
|
|
402,135 |
|
|
|
447,755 |
|
Selling, engineering and administrative expenses |
|
|
133,956 |
|
|
|
157,445 |
|
|
|
262,720 |
|
|
|
305,018 |
|
Net loss on sales of businesses and assets |
|
|
|
|
|
|
|
|
|
|
2,597 |
|
|
|
18 |
|
Goodwill impairment |
|
|
31,873 |
|
|
|
|
|
|
|
31,873 |
|
|
|
|
|
Restructuring and other impairment charges |
|
|
6,166 |
|
|
|
2,591 |
|
|
|
8,629 |
|
|
|
11,447 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before interest and taxes |
|
|
34,016 |
|
|
|
74,280 |
|
|
|
96,316 |
|
|
|
131,272 |
|
Interest expense |
|
|
21,999 |
|
|
|
31,376 |
|
|
|
47,401 |
|
|
|
62,459 |
|
Interest income |
|
|
(1,463 |
) |
|
|
(446 |
) |
|
|
(1,677 |
) |
|
|
(1,407 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before taxes |
|
|
13,480 |
|
|
|
43,350 |
|
|
|
50,592 |
|
|
|
70,220 |
|
Taxes on income from continuing operations |
|
|
6,889 |
|
|
|
14,477 |
|
|
|
17,351 |
|
|
|
26,139 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
6,591 |
|
|
|
28,873 |
|
|
|
33,241 |
|
|
|
44,081 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income from discontinued operations (including gain
on disposal of $275,787 in 2009 and loss on disposal of $4,808
for the three and six month periods in 2008) |
|
|
|
|
|
|
14,132 |
|
|
|
297,975 |
|
|
|
29,327 |
|
Taxes (benefit) on income from discontinued operations |
|
|
(181 |
) |
|
|
(1,036 |
) |
|
|
98,837 |
|
|
|
(630 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations |
|
|
181 |
|
|
|
15,168 |
|
|
|
199,138 |
|
|
|
29,957 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
6,772 |
|
|
|
44,041 |
|
|
|
232,379 |
|
|
|
74,038 |
|
Less: Net income attributable to noncontrolling interest |
|
|
302 |
|
|
|
259 |
|
|
|
538 |
|
|
|
446 |
|
Income from discontinued operations attributable to
noncontrolling interest |
|
|
|
|
|
|
8,839 |
|
|
|
9,860 |
|
|
|
15,706 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to common shareholders |
|
$ |
6,470 |
|
|
$ |
34,943 |
|
|
$ |
221,981 |
|
|
$ |
57,886 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share available to common shareholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
0.16 |
|
|
$ |
0.72 |
|
|
$ |
0.82 |
|
|
$ |
1.10 |
|
Income from discontinued operations |
|
$ |
|
|
|
$ |
0.16 |
|
|
$ |
4.77 |
|
|
$ |
0.36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.16 |
|
|
$ |
0.88 |
|
|
$ |
5.59 |
|
|
$ |
1.47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
0.16 |
|
|
$ |
0.72 |
|
|
$ |
0.82 |
|
|
$ |
1.10 |
|
Income from discontinued operations |
|
$ |
|
|
|
$ |
0.16 |
|
|
$ |
4.74 |
|
|
$ |
0.36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.16 |
|
|
$ |
0.88 |
|
|
$ |
5.56 |
|
|
$ |
1.46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends per share |
|
$ |
0.34 |
|
|
$ |
0.34 |
|
|
$ |
0.68 |
|
|
$ |
0.66 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
39,717 |
|
|
|
39,562 |
|
|
|
39,704 |
|
|
|
39,508 |
|
Diluted |
|
|
39,921 |
|
|
|
39,831 |
|
|
|
39,899 |
|
|
|
39,770 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts attributable to common shareholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations, net of tax |
|
$ |
6,289 |
|
|
$ |
28,614 |
|
|
$ |
32,703 |
|
|
$ |
43,635 |
|
Discontinued operations, net of tax |
|
|
181 |
|
|
|
6,329 |
|
|
|
189,278 |
|
|
|
14,251 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
6,470 |
|
|
$ |
34,943 |
|
|
$ |
221,981 |
|
|
$ |
57,886 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
2
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
June 28, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
114,270 |
|
|
$ |
107,275 |
|
Accounts receivable, net |
|
|
275,320 |
|
|
|
311,908 |
|
Inventories, net |
|
|
411,231 |
|
|
|
424,653 |
|
Prepaid expenses and other current assets |
|
|
20,998 |
|
|
|
21,373 |
|
Income taxes receivable |
|
|
37,621 |
|
|
|
17,958 |
|
Deferred tax assets |
|
|
60,110 |
|
|
|
66,009 |
|
Assets held for sale |
|
|
8,689 |
|
|
|
8,210 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
928,239 |
|
|
|
957,386 |
|
Property, plant and equipment, net |
|
|
329,466 |
|
|
|
374,292 |
|
Goodwill |
|
|
1,444,424 |
|
|
|
1,474,123 |
|
Intangibles and other assets, net |
|
|
1,060,418 |
|
|
|
1,090,852 |
|
Investments in affiliates |
|
|
15,951 |
|
|
|
28,105 |
|
Deferred tax assets |
|
|
265 |
|
|
|
1,986 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
3,778,763 |
|
|
$ |
3,926,744 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Current borrowings |
|
$ |
5,736 |
|
|
$ |
108,853 |
|
Accounts payable |
|
|
104,295 |
|
|
|
139,677 |
|
Accrued expenses |
|
|
106,361 |
|
|
|
125,183 |
|
Payroll and benefit-related liabilities |
|
|
71,332 |
|
|
|
83,129 |
|
Derivative liabilities |
|
|
20,005 |
|
|
|
27,370 |
|
Accrued interest |
|
|
24,103 |
|
|
|
26,888 |
|
Income taxes payable |
|
|
3,439 |
|
|
|
12,613 |
|
Deferred tax liabilities |
|
|
5,735 |
|
|
|
2,227 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
341,006 |
|
|
|
525,940 |
|
Long-term borrowings |
|
|
1,299,686 |
|
|
|
1,437,538 |
|
Deferred tax liabilities |
|
|
335,180 |
|
|
|
324,678 |
|
Pension and postretirement benefit liabilities |
|
|
172,650 |
|
|
|
169,841 |
|
Other liabilities |
|
|
163,683 |
|
|
|
182,864 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
2,312,205 |
|
|
|
2,640,861 |
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
Total common shareholders equity |
|
|
1,462,050 |
|
|
|
1,246,455 |
|
Noncontrolling interest |
|
|
4,508 |
|
|
|
39,428 |
|
|
|
|
|
|
|
|
Total equity |
|
|
1,466,558 |
|
|
|
1,285,883 |
|
|
|
|
|
|
|
|
Total liabilities and equity |
|
$ |
3,778,763 |
|
|
$ |
3,926,744 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
3
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Cash Flows from Operating Activities of Continuing Operations: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
232,379 |
|
|
$ |
74,038 |
|
Adjustments to reconcile net income to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Income from discontinued operations |
|
|
(199,138 |
) |
|
|
(29,957 |
) |
Depreciation expense |
|
|
29,237 |
|
|
|
31,115 |
|
Amortization expense of intangible assets |
|
|
22,230 |
|
|
|
23,503 |
|
Amortization expense of deferred financing costs |
|
|
3,610 |
|
|
|
2,510 |
|
Impairment of long-lived assets |
|
|
2,474 |
|
|
|
|
|
Impairment of goodwill |
|
|
31,873 |
|
|
|
|
|
Stock-based compensation |
|
|
4,236 |
|
|
|
4,241 |
|
Net loss on sales of businesses and assets |
|
|
2,597 |
|
|
|
18 |
|
Other |
|
|
3,024 |
|
|
|
1,811 |
|
Changes in operating assets and liabilities, net of effects of acquisitions: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
11,590 |
|
|
|
(10,417 |
) |
Inventories |
|
|
(7,218 |
) |
|
|
1,855 |
|
Prepaid expenses and other current assets |
|
|
1,445 |
|
|
|
5,537 |
|
Accounts payable and accrued expenses |
|
|
(41,163 |
) |
|
|
10,653 |
|
Income taxes payable and deferred income taxes |
|
|
(116,493 |
) |
|
|
(129,679 |
) |
|
|
|
|
|
|
|
Net cash used in operating activities from continuing operations |
|
|
(19,317 |
) |
|
|
(14,772 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Financing Activities of Continuing Operations: |
|
|
|
|
|
|
|
|
Proceeds from long-term borrowings |
|
|
10,000 |
|
|
|
|
|
Reduction in long-term borrowings |
|
|
(249,178 |
) |
|
|
(38,983 |
) |
Decrease in notes payable and current borrowings |
|
|
(651 |
) |
|
|
(1,340 |
) |
Proceeds from stock compensation plans |
|
|
367 |
|
|
|
5,586 |
|
Payments to noncontrolling interest shareholders |
|
|
(295 |
) |
|
|
(442 |
) |
Dividends |
|
|
(27,014 |
) |
|
|
(26,086 |
) |
|
|
|
|
|
|
|
Net cash used in financing activities from continuing operations |
|
|
(266,771 |
) |
|
|
(61,265 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Investing Activities of Continuing Operations: |
|
|
|
|
|
|
|
|
Expenditures for property, plant and equipment |
|
|
(15,078 |
) |
|
|
(16,782 |
) |
Proceeds from sales of businesses and assets, net of cash sold |
|
|
300,000 |
|
|
|
|
|
Payments for businesses and intangibles acquired, net of cash acquired |
|
|
(541 |
) |
|
|
(6,083 |
) |
Investments in affiliates |
|
|
|
|
|
|
(250 |
) |
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities from continuing
operations |
|
|
284,381 |
|
|
|
(23,115 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Discontinued Operations: |
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
17,688 |
|
|
|
31,111 |
|
Net cash used in financing activities |
|
|
(11,075 |
) |
|
|
(24,500 |
) |
Net cash used in investing activities |
|
|
(1,103 |
) |
|
|
(1,023 |
) |
|
|
|
|
|
|
|
Net cash provided by discontinued operations |
|
|
5,510 |
|
|
|
5,588 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
3,192 |
|
|
|
(4,536 |
) |
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents |
|
|
6,995 |
|
|
|
(98,100 |
) |
Cash and cash equivalents at the beginning of the period |
|
|
107,275 |
|
|
|
201,342 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at the end of the period |
|
$ |
114,270 |
|
|
$ |
103,242 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
4
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED
STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
|
|
|
|
Other |
|
|
Treasury |
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
|
Paid in |
|
|
Retained |
|
|
Comprehensive |
|
|
Stock |
|
|
Noncontrolling |
|
|
Total |
|
|
Comprehensive |
|
|
|
Shares |
|
|
Dollars |
|
|
Capital |
|
|
Earnings |
|
|
Income |
|
|
Shares |
|
|
Dollars |
|
|
Interest |
|
|
Equity |
|
|
Income |
|
|
|
(Dollars and shares in thousands, except per share) |
|
Balance at December 31,
2007 |
|
|
41,794 |
|
|
$ |
41,794 |
|
|
$ |
252,108 |
|
|
$ |
1,118,053 |
|
|
$ |
56,919 |
|
|
|
2,343 |
|
|
$ |
(140,031 |
) |
|
$ |
42,183 |
|
|
$ |
1,371,026 |
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
57,886 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,152 |
|
|
|
74,038 |
|
|
$ |
74,038 |
|
Split-dollar life
insurance arrangements
adjustment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,874 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,874 |
) |
|
|
(1,874 |
) |
Cash dividends ($0.66
per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(26,086 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(26,086 |
) |
|
|
|
|
Financial instruments
marked to market, net
of tax of $(105) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(170 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(170 |
) |
|
|
(170 |
) |
Cumulative translation
adjustment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,849 |
|
|
|
|
|
|
|
|
|
|
|
(132 |
) |
|
|
24,717 |
|
|
|
24,717 |
|
Pension liability
adjustment, net of tax
of $1,433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
468 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
468 |
|
|
|
468 |
|
Distributions to
noncontrolling interest
shareholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(24,942 |
) |
|
|
(24,942 |
) |
|
|
|
|
Disposition of
noncontrolling interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
804 |
|
|
|
804 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
97,179 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued under
compensation plans |
|
|
138 |
|
|
|
138 |
|
|
|
9,450 |
|
|
|
|
|
|
|
|
|
|
|
(15 |
) |
|
|
648 |
|
|
|
|
|
|
|
10,236 |
|
|
|
|
|
Deferred compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8 |
) |
|
|
332 |
|
|
|
|
|
|
|
332 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 29, 2008 |
|
|
41,932 |
|
|
$ |
41,932 |
|
|
$ |
261,558 |
|
|
$ |
1,147,979 |
|
|
$ |
82,066 |
|
|
|
2,320 |
|
|
$ |
(139,051 |
) |
|
$ |
34,065 |
|
|
$ |
1,428,549 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
2008 |
|
|
41,995 |
|
|
$ |
41,995 |
|
|
$ |
268,263 |
|
|
$ |
1,182,906 |
|
|
$ |
(108,202 |
) |
|
|
2,311 |
|
|
$ |
(138,507 |
) |
|
$ |
39,428 |
|
|
$ |
1,285,883 |
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
221,981 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,398 |
|
|
|
232,379 |
|
|
$ |
232,379 |
|
Cash dividends ($0.68
per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(27,014 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(27,014 |
) |
|
|
|
|
Financial instruments
marked to market, net
of tax of $5,690 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,787 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,787 |
|
|
|
13,787 |
|
Cumulative translation
adjustment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
727 |
|
|
|
|
|
|
|
|
|
|
|
(5 |
) |
|
|
722 |
|
|
|
722 |
|
Pension liability
adjustment, net of tax
of $826 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,524 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,524 |
|
|
|
1,524 |
|
Distributions to
noncontrolling interest
shareholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(295 |
) |
|
|
(295 |
) |
|
|
|
|
Disposition of
noncontrolling interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(45,019 |
) |
|
|
(45,019 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
248,412 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued under
compensation plans |
|
|
10 |
|
|
|
10 |
|
|
|
3,277 |
|
|
|
|
|
|
|
|
|
|
|
(15 |
) |
|
|
961 |
|
|
|
|
|
|
|
4,248 |
|
|
|
|
|
Deferred compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(9 |
) |
|
|
343 |
|
|
|
|
|
|
|
343 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 28, 2009 |
|
|
42,005 |
|
|
$ |
42,005 |
|
|
$ |
271,540 |
|
|
$ |
1,377,873 |
|
|
$ |
(92,164 |
) |
|
|
2,287 |
|
|
$ |
(137,203 |
) |
|
$ |
4,507 |
|
|
$ |
1,466,558 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
5
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 Basis of presentation
We prepared the accompanying unaudited condensed consolidated financial statements of Teleflex
Incorporated on the same basis as our annual consolidated financial statements, with the exception
of changes resulting from the adoption of new accounting guidance during the first six months of
2009. Please see Note 2 for a description of the new guidance. We reclassified certain prior year
amounts to conform with our current year presentation.
In the opinion of management, our financial statements reflect all adjustments, which are of a
normal recurring nature, necessary for presentation of financial statements for interim periods in
accordance with U.S. generally accepted accounting principles (GAAP) and with Rule 10-01 of SEC
Regulation S-X, which sets forth the instructions for financial statements included in Form 10-Q.
The preparation of consolidated financial statements in conformity with GAAP requires management to
make estimates and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of our financial statements, as well as
the reported amounts of revenue and expenses during the reporting periods. Actual results could
differ from those estimates.
We have evaluated the period from June 28, 2009, the date of the financial statements, through
July 27, 2009 the date of the issuance and filing of the financial statements for subsequent
events. On July 20, 2009 the Company announced that it had entered into a definitive agreement to
sell its Power Systems business. See Note 18 Subsequent Event for a further discussion.
In accordance with applicable accounting standards, the accompanying condensed financial
statements do not include all of the information and footnote disclosures that are required to be
included in our annual consolidated financial statements. The year-end condensed balance sheet data
was derived from audited financial statements, but does not include all disclosures required by
accounting principles generally accepted in the United States. Accordingly, our quarterly condensed
financial statements should be read in conjunction with the consolidated financial statements
included in our Annual Report on Form 10-K for the year ended December 31, 2008.
As used in this report, the terms we, us, our, Teleflex and the Company mean
Teleflex Incorporated and its subsidiaries, unless the context indicates otherwise. The results of
operations for the periods reported are not necessarily indicative of those that may be expected
for a full year.
Note 2 New accounting standards
The financial statements included in this report reflect changes resulting from the recent
adoption of several accounting pronouncements. The subject matter of the changes, and the footnotes
in which they appear, are as follows:
Evaluation period of subsequent events in Note 1;
Fair value of long-term debt in Note 8;
Disclosure of derivative instruments and hedging activities in Note 9; and
Fair value measurements in Note 10.
We describe below several accounting pronouncements that we either recently adopted (including
those reflected in the footnotes referenced above) or we will adopt in the near future.
Fair Value Measurements: In September 2006, the Financial Accounting Standards Board (FASB)
issued Statement of Financial Accounting Standards (SFAS) No. 157, Fair Value Measurements.
SFAS No. 157 establishes a common definition of fair value to be applied to US GAAP that requires
the use of fair value, establishes a framework for measuring fair value, and expands disclosure
about such fair value measurements. Except as noted below, SFAS No. 157 became effective for fiscal
years beginning after November 15, 2007.
In February 2008, the FASB issued FASB Staff Position (FSP) No. FAS 157-2, Partial Deferral of
the Effective Date of Statement 157. FSP No. FAS 157-2 delays the effective date of SFAS No. 157
to fiscal years beginning after November 15, 2008 for all nonfinancial assets and nonfinancial
liabilities, except those that are recognized or disclosed at fair value in the financial
statements
on a recurring basis (at least annually). The Company adopted SFAS No. 157 as of January 1, 2008
with respect to financial assets and financial liabilities. The Company adopted the provisions of
FSP No. FAS 157-2 as of January 1, 2009. SFAS No. 157 and the related FSP No. FAS 157-2 did not
have a material impact on the Companys results of operations, cash flows or financial position
upon adoption. Refer to Note 10 for additional discussion on fair value measurements.
6
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Business Combinations: In December 2007, the FASB issued SFAS No. 141(R), Business
Combinations. SFAS No. 141(R) replaces SFAS No. 141, Business Combinations. SFAS No. 141(R)
retains the fundamental requirements in SFAS No. 141 that the acquisition method of accounting
(which SFAS No. 141 called the purchase method) be used for all business combinations and that an
acquirer be identified for each business combination. SFAS No. 141(R) defines the acquirer as the
entity that obtains control of one or more businesses in the business combination and establishes
the acquisition date as the date that the acquirer achieves control. SFAS No. 141(R)s scope is
broader than that of SFAS No. 141, which applied only to business combinations in which control was
obtained by transferring consideration.
SFAS No. 141(R) replaces SFAS No. 141s cost-allocation process and requires an acquirer to
recognize the assets acquired, the liabilities assumed, and any noncontrolling interest in the
acquiree at the acquisition date, measured at their fair values as of that date, with limited
exceptions. In addition, SFAS No. 141(R) changes the allocation and treatment of
acquisition-related costs, restructuring costs that the acquirer expected but was not obligated to
incur, the recognition of assets and liabilities assumed arising from contingencies and the
recognition and measurement of goodwill. This statement is effective for fiscal years beginning
after December 15, 2008 and is to be applied prospectively to business combinations.
On April 1, 2009, the FASB issued FSP No. FAS 141(R)-1, Accounting for Assets Acquired and
Liabilities Assumed in a Business Combination That Arise from Contingencies. FSP No. FAS 141(R)-1
amends SFAS No. 141(R) and clarifies issues that arose regarding initial recognition and
measurement, subsequent measurement and accounting and disclosure of assets and liabilities arising
from contingencies in a business combination. FSP No. FAS 141(R)-1 is effective for fiscal years
beginning after December 15, 2008.
SFAS No. 141(R) and the related FSP No. FAS 141(R)-1 did not have an impact on the Companys
results of operations, cash flows or financial position upon adoption; however, future transactions
entered into by the Company will be evaluated under the requirements of these standards.
Noncontrolling Interests: In December 2007, the FASB issued SFAS No. 160, Noncontrolling
Interests in Consolidated Financial Statements an amendment of ARB No. 51. SFAS No. 160 amends
Accounting Research Bulletin (ARB) No. 51 to establish accounting and reporting standards for the
noncontrolling interest in a subsidiary, sometimes referred to as minority interest, and for the
deconsolidation of a subsidiary. SFAS No. 160 clarifies that a noncontrolling interest in a
subsidiary is an ownership interest in the consolidated entity that should be reported as equity in
the consolidated financial statements. SFAS No. 160 requires that a noncontrolling interest in
subsidiaries held by parties other than the parent be clearly identified, labeled, and presented in
the consolidated statement of financial position within equity, but separate from the parents
equity, that the amount of consolidated net income attributable to the parent and to the
noncontrolling interest be clearly identified and presented on the face of the consolidated
statement of income, that the changes in a parents ownership interest while the parent retains its
controlling financial interest in its subsidiary be accounted for consistently as equity
transactions and that when a subsidiary is deconsolidated, any retained noncontrolling equity
investment in the former subsidiary be initially measured at fair value. This statement is
effective for fiscal years beginning after December 15, 2008. The Company adopted SFAS No. 160 as
of January 1, 2009. The adoption of SFAS No. 160 has changed the presentation of noncontrolling
interests on our income statement, balance sheet and changes in shareholders equity.
Disclosures about derivative instruments and hedging activities: In March 2008, the FASB
issued SFAS No. 161 Disclosures about Derivative Instruments and Hedging Activities an
amendment of FASB Statement No. 133, which requires enhanced disclosures about derivative and
hedging activities. Companies are required to provide enhanced disclosures about (a) how and why a
company uses derivative instruments, (b) how derivative instruments and related hedged items are
accounted for under SFAS No. 133 and related interpretations, and (c) how derivative instruments
and related hedged items affect the companys financial position, financial performance, and cash
flows. SFAS No. 161 is effective for financial statements issued for fiscal and interim periods
beginning after November 15, 2008. The Company adopted SFAS No. 161 as of January 1, 2009. Refer
to Note 9 for the enhanced disclosures related to the Companys derivative instruments.
7
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating
Securities: In June 2008, the FASB issued FSP EITF 03-6-1 Determining Whether Instruments Granted
in Share-Based Payment Transactions Are Participating Securities, which addresses whether unvested
instruments granted in share-based payment transactions that contain nonforfeitable rights to
dividends or dividend equivalents are participating securities subject to the two-class method of
computing earnings per share
under SFAS No. 128, Earnings Per Share. FSP EITF 03-6-1 is effective for financial statements
issued for fiscal years beginning after December 15, 2008 and interim periods within those years.
The Company adopted FSP EITF 03-6-1 January 1, 2009. FSP EITF 03-6-1 did not result in a change in
the Companys earnings per share or diluted earnings per share upon its adoption.
Determination of the Useful Life of Intangible Assets: In April 2008, the FASB issued FSP No.
FAS 142-3, Determination of the Useful Life of Intangible Assets, which amends SFAS No. 142,
Goodwill and Other Intangible Assets with respect to the factors that should be considered in
developing renewal or extension assumptions used to determine the useful lives for intangible
assets. FSP No. FAS 142-3 requires an entity to consider its own historical experience in renewing
or extending similar arrangements, regardless of whether those arrangements have explicit renewal
or extension provisions, when determining the useful life of an intangible asset. In the absence of
such experience, an entity shall consider the assumptions that market participants would use about
renewal or extension, adjusted for entity-specific factors. FSP No. FAS 142-3 is effective for
qualifying intangible assets acquired by the Company on or after January 1, 2009. The application
of FSP No. FAS 142-3 did not have a material impact on the Companys results of operations, cash
flows or financial position upon adoption; however, future transactions entered into by the Company
will be subject to the requirements of FSP No. FAS 142-3.
Employers Disclosures about Postretirement Benefit Plan Assets: In December 2008, the FASB
issued FSP No. FAS 132(R)-1, Employers Disclosures about Postretirement Benefit Plan Assets (FSP
No. FAS 132(R)-1), which requires additional disclosures for employers pension and other
postretirement benefit plan assets. Disclosures regarding fair value measurements of pension and
other postretirement benefit plan assets were not included within the scope of SFAS No. 157. FSP
No. FAS 132(R)-1 requires employers to disclose information about fair value measurements of plan
assets that would be similar to the disclosures about fair value measurements required under SFAS
No. 157, the investment policies and strategies for the major categories of plan assets, and
significant concentrations of risk within plan assets. FSP No. FAS 132(R)-1 will be effective for
the Company as of December 31, 2009. As FSP No. FAS 132(R)-1 provides only disclosure requirements,
the adoption of this standard will not have a material impact on the Companys results of
operations, cash flows or financial position.
Fair Value of Financial Instruments: In April 2009, the FASB issued FSP No. FAS 107-1 and
Accounting Principles Board (APB) No. 28-1, Interim Disclosures about Fair Value of Financial
Instruments, which requires disclosures about fair value of financial instruments for interim
reporting periods as well as in annual financial statements. The FSP also amends APB Opinion No.
28, Interim Financial Reporting, to require those disclosures in summarized financial information
at interim reporting periods. FSP No. FAS 107-1 requires that an entity disclose in the body or in
the accompanying notes of its financial information the fair value of all financial instruments for
which it is practicable to estimate that value, whether recognized or not recognized in the
statement of financial position, as required by SFAS No. 107. In addition, an entity shall also
disclose the method(s) and significant assumptions used to estimate the fair value of financial
instruments.
FSP No. FAS 107-1 is effective for interim reporting periods ending after June 15, 2009. FSP
No. FAS 107-1 does not require disclosures for earlier periods presented for comparative purposes
at initial adoption. In periods after initial adoption, this FSP requires comparative disclosures
only for periods ending after initial adoption. The Company adopted FSP No. FAS 107-1 as of June
28, 2009. Refer to Note 8 for the interim fair value disclosures related to the Companys financial
instruments.
Determining Fair Value When the Volume and Level of Activity for the Asset or Liability Have
Significantly Decreased and Identifying Transactions That Are Not Orderly: In April 2009, the FASB
issued FSP No. FAS 157-4 Determining Fair Value When the Volume and Level of Activity for the
Asset or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly.
FSP No. FAS 157-4 provides additional guidance for estimating fair value in accordance with SFAS
No. 157, Fair Value Measurements, when the volume and level of activity for the asset or
liability have significantly decreased. FSP No. FAS 157-4 also includes guidance on identifying
circumstances that indicate a transaction is not orderly.
FSP No. FAS 157-4 is effective for interim and annual reporting periods ending after June 15,
2009, and shall be applied prospectively. FSP No. FAS 157-4 does not require disclosures for
earlier periods presented for comparative purposes at initial adoption. In periods after initial
adoption, comparative disclosures are required but only for periods ending after initial adoption.
The Company adopted FSP No. FAS 157-4 as of June 28, 2009. The adoption of the standard did not
have a material impact on the Companys results of operations, cash flows or financial position.
Subsequent Events: In May 2009, the FASB issued SFAS 165, Subsequent Events, which
establishes reporting and disclosure requirements based on the existence of conditions at the date
of the balance sheet for events or transactions that occurred after the balance sheet date but
before the financial statements are issued or are available to be issued. Companies are required
to disclose the date through which subsequent events have been evaluated and whether that date is
the date the financial statements were issued or were available to be issued. SFAS No. 165 is
effective for financial statements issued for fiscal and interim periods ending after June 15, 2009
and is applied prospectively. The Company adopted SFAS 165 as of June 28, 2009.
8
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Accounting for Transfers of Financial Assets an amendment of FASB Statement No. 140: In
June 2009, the FASB issued SFAS No. 166 Accounting for Transfers of Financial Assets an
amendment of FASB Statement No. 140, to improve the information that is reported in financial
statements about the transfer of financial assets and the effects of transfers of financial assets
on financial position, financial performance and cash flows and a transferors continuing
involvement, if any, with transferred financial assets. In addition, SFAS No. 166 eliminates the
concept of qualifying special purpose entities. SFAS No. 166 limits the circumstances in which a
financial asset or a portion of a financial asset should be derecognized when the transferor has
not transferred the entire original financial asset to an entity that is not consolidated with the
transferor in the financial statements being presented and/or when the transferor has continuing
involvement with the transferred financial asset. SFAS No. 166 is effective for interim periods as
of the beginning of the first annual reporting period beginning after November 15, 2009. The
Company is currently evaluating the provisions of SFAS No. 166 to determine the impact on the
Companys results of operations, cash flows or financial position.
Amendments to FASB Interpretation No. 46(R): In June 2009, the FASB issued SFAS No. 167
Amendments to FASB Interpretation No. 46(R), which amends Interpretation 46(R) to require an
enterprise to perform an analysis to determine whether the enterprises variable interest or
interests give it a controlling financial interest in a variable interest entity (which would
result in the enterprise being deemed the primary beneficiary of that entity and, therefore,
obligated to consolidate the variable interest entity in its financial statements); to require
ongoing reassessments of whether an enterprise is the primary beneficiary of a variable interest
entity; to revise guidance for determining whether an entity is a variable interest entity; and to
require enhanced disclosures that will provide more transparent information about an enterprises
involvement with a variable interest entity. FAS No. 167 is effective for interim periods as of the
beginning of the first annual reporting period beginning after November 15, 2009. The Company is
currently evaluating the provisions of SFAS No. 167 to determine the impact on the Companys
results of operations, cash flows or financial position.
The FASB Accounting Standards CodificationTM and the Hierarchy of Generally
Accepted Accounting Principles a replacement of FASB Statement No. 162: In June 2009, the FASB
issued SFAS No. 168, The FASB Accounting Standards CodificationTM and the Hierarchy of
Generally Accepted Accounting Principles a replacement of FASB Statement No. 162. SFAS No. 168
replaces SFAS No. 162, The Hierarchy of Generally Accepted Accounting Principles. SFAS No. 168
identifies the sources of accounting principles and the framework for selecting the principles used
in the preparation of financial statements of nongovernmental entities that are presented in
conformity with GAAP in the United States (the GAAP hierarchy). SFAS No. 168 establishes the
Codification as the source of authoritative GAAP recognized by the FASB to be applied by
nongovernmental entities. Rules and interpretive releases of the SEC under federal securities laws
are also sources of authoritative GAAP for SEC registrants. All guidance contained in the
Codification carries an equal level of authority. SFAS No. 168 is effective for financial
statements issued for interim and annual periods ending after September 15, 2009.
Note 3 Integration
Integration of Arrow
In connection with the acquisition of Arrow International, Inc. (Arrow) in October 2007, the
Company formulated a plan related to the integration of Arrow and the Companys Medical businesses.
The integration plan focuses on the closure of Arrow corporate functions and the consolidation of
manufacturing, sales, marketing, and distribution functions in North America, Europe and Asia. The
Company finalized its estimate of the costs to implement the plan in the fourth quarter of 2008.
The Company has accrued estimates for certain costs, related primarily to personnel reductions and
facility closures and the termination of certain distribution agreements at the date of
acquisition, in accordance with EITF Issue No. 95-3, Recognition of Liabilities in Connection with
a Purchase Business Combination.
9
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The following table provides information relating to changes in the accrued liability
associated with the Arrow integration plan during the six months ended June 28, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
December 31, |
|
|
Adjustments to |
|
|
|
|
|
|
|
|
|
|
June 28, |
|
|
|
2008 |
|
|
Reserve |
|
|
Payments |
|
|
Translation |
|
|
2009 |
|
|
|
(Dollars in millions) |
|
Termination benefits |
|
$ |
4.3 |
|
|
$ |
(0.3 |
) |
|
$ |
(0.1 |
) |
|
$ |
|
|
|
$ |
3.9 |
|
Facility closure costs |
|
|
0.8 |
|
|
|
|
|
|
|
(0.1 |
) |
|
|
(0.1 |
) |
|
|
0.6 |
|
Contract termination costs |
|
|
4.8 |
|
|
|
0.1 |
|
|
|
(1.9 |
) |
|
|
(0.3 |
) |
|
|
2.7 |
|
Other integration costs |
|
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
10.6 |
|
|
$ |
(0.2 |
) |
|
$ |
(2.1 |
) |
|
$ |
(0.4 |
) |
|
$ |
7.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
It is anticipated that a majority of these costs will be paid in 2009; however, some portions
of the contract termination costs for leased facilities will extend to 2013.
In conjunction with the plan for the integration of Arrow and the Companys Medical
businesses, the Company has taken actions that affect employees and facilities of Teleflex. This
aspect of the integration plan is explained in Note 4, Restructuring, and costs incurred for this
aspect of the plan are charged to earnings and included in restructuring and other impairment
charges within the condensed consolidated statement of operations for the periods in which the
costs are incurred.
Note 4 Restructuring
The amounts included in restructuring and other impairment charges in the condensed
consolidated statement of income for the three and six month periods ended June 28, 2009 and June
29, 2008 consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
2008 Commercial Segment Program |
|
$ |
917 |
|
|
$ |
|
|
|
$ |
2,055 |
|
|
$ |
|
|
2007 Arrow Integration Program |
|
|
2,775 |
|
|
|
2,734 |
|
|
|
4,100 |
|
|
|
10,780 |
|
2006 Restructuring Program |
|
|
|
|
|
|
(143 |
) |
|
|
|
|
|
|
667 |
|
Impairment charges intangibles and fixed assets |
|
|
2,474 |
|
|
|
|
|
|
|
2,474 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring and other impairment charges |
|
$ |
6,166 |
|
|
$ |
2,591 |
|
|
$ |
8,629 |
|
|
$ |
11,447 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008 Commercial Segment Program
In December 2008, the Company began certain restructuring initiatives with respect to the
Companys Commercial Segment. These initiatives involve the consolidation of operations and a
related reduction in workforce at certain of the Companys facilities in North America and Europe.
The Company determined to undertake these initiatives as a means to address an expected
continuation of weakness in the marine and industrial markets.
The charges associated with the 2008 Commercial Segment restructuring program that are
included in restructuring and other impairment charges in the condensed consolidated statements of
income during the three and six month periods ended June 28, 2009 were as follows:
|
|
|
|
|
|
|
|
|
|
|
Commercial |
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, 2009 |
|
|
June 28, 2009 |
|
|
|
(Dollars in thousands) |
|
Termination benefits |
|
$ |
789 |
|
|
$ |
1,927 |
|
Facility closure costs |
|
|
128 |
|
|
|
128 |
|
|
|
|
|
|
|
|
|
|
$ |
917 |
|
|
$ |
2,055 |
|
|
|
|
|
|
|
|
10
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The following table provides information relating to changes in the accrued liability
associated with the 2008 Commercial Segment restructuring program during the six months ended June
28, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
December 31, |
|
|
Subsequent |
|
|
|
|
|
|
|
|
|
|
June 28, |
|
|
|
2008 |
|
|
Accruals |
|
|
Payments |
|
|
Translation |
|
|
2009 |
|
|
|
(Dollars in thousands) |
|
Termination benefits |
|
$ |
449 |
|
|
$ |
1,927 |
|
|
$ |
(2,137 |
) |
|
$ |
7 |
|
|
$ |
246 |
|
Facility closure costs |
|
|
|
|
|
|
128 |
|
|
|
(128 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
449 |
|
|
$ |
2,055 |
|
|
$ |
(2,265 |
) |
|
$ |
7 |
|
|
$ |
246 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 28, 2009, the Company has completed the 2008 Commercial Segment restructuring
program.
Termination benefits are comprised of severance-related payments for all employees terminated
in connection with the 2008 Commercial Segment restructuring program. Facility closure costs relate
primarily to costs to prepare a facility for closure.
2007 Arrow Integration Program
In connection with the acquisition of Arrow, the Company formulated a plan related to the
integration of Arrow and the Companys Medical businesses. The integration plan focuses on the
closure of Arrow corporate functions and the consolidation of manufacturing, sales, marketing, and
distribution functions in North America, Europe and Asia. In as much as the actions affect
employees and facilities of Arrow, the resultant costs have been included in the allocation of the
purchase price of Arrow. Costs related to actions that affect employees and facilities of Teleflex
are charged to earnings and included in restructuring and other impairment charges within the
condensed consolidated statement of operations.
The charges associated with the 2007 Arrow integration program that were included in
restructuring and other impairment charges for the three and six month periods ended June 28, 2009
and June 29, 2008, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Termination benefits |
|
$ |
1,467 |
|
|
$ |
1,792 |
|
|
$ |
2,564 |
|
|
$ |
9,838 |
|
Facility closure costs |
|
|
165 |
|
|
|
|
|
|
|
216 |
|
|
|
|
|
Contract termination costs |
|
|
829 |
|
|
|
806 |
|
|
|
891 |
|
|
|
806 |
|
Other restructuring costs |
|
|
314 |
|
|
|
136 |
|
|
|
429 |
|
|
|
136 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,775 |
|
|
$ |
2,734 |
|
|
$ |
4,100 |
|
|
$ |
10,780 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table provides information relating to changes in the accrued liability
associated with the 2007 Arrow integration program during the six months ended June 28, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
December 31, |
|
|
Subsequent |
|
|
|
|
|
|
|
|
|
|
June 28, |
|
|
|
2008 |
|
|
Accruals |
|
|
Payments |
|
|
Translation |
|
|
2009 |
|
|
|
(Dollars in thousands) |
|
Termination benefits |
|
$ |
7,815 |
|
|
$ |
2,564 |
|
|
$ |
(5,829 |
) |
|
$ |
(278 |
) |
|
$ |
4,272 |
|
Facility closure costs |
|
|
601 |
|
|
|
216 |
|
|
|
(386 |
) |
|
|
(16 |
) |
|
|
415 |
|
Contract termination costs |
|
|
|
|
|
|
891 |
|
|
|
(641 |
) |
|
|
8 |
|
|
|
258 |
|
Other restructuring costs |
|
|
159 |
|
|
|
429 |
|
|
|
(471 |
) |
|
|
(3 |
) |
|
|
114 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
8,575 |
|
|
$ |
4,100 |
|
|
$ |
(7,327 |
) |
|
$ |
(289 |
) |
|
$ |
5,059 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination benefits are comprised of severance-related payments for all employees terminated
in connection with the 2007 Arrow integration program. Facility closure costs related primarily to
costs that will be incurred to prepare a facility for closure. Contract termination costs related
primarily to the termination of leases in conjunction with the consolidation of facilities.
11
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of June 28, 2009, the Company expects to incur the following restructuring expenses
associated with the 2007 Arrow integration program in its Medical Segment over the next two years:
|
|
|
|
(Dollars in millions) |
Termination benefits
|
$ |
3.5 4.5 |
Facility closure costs
|
|
0.8 1.0 |
Contract termination costs
|
|
5.5 6.5 |
Other restructuring costs
|
|
0.1 0.3 |
|
|
|
$ |
9.9 12.3 |
|
|
2006 Restructuring Program
In June 2006, the Company began certain restructuring initiatives that affected all three of
the Companys reporting segments. These initiatives involved the consolidation of operations and a
related reduction in workforce at several of the Companys facilities in Europe and North America.
The Company determined to undertake these initiatives as a means to improving operating performance
and to better leverage the Companys existing resources.
For the three and six month periods ended June 29, 2008, the charges associated with the 2006
restructuring program that are included in restructuring and other impairment charges were as
follows:
|
|
|
|
|
|
|
|
|
|
|
Medical |
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 29, 2008 |
|
|
June 29, 2008 |
|
|
|
(Dollars in thousands) |
|
Termination benefits |
|
$ |
(182 |
) |
|
$ |
589 |
|
Contract termination costs |
|
|
39 |
|
|
|
78 |
|
|
|
|
|
|
|
|
|
|
$ |
(143 |
) |
|
$ |
667 |
|
|
|
|
|
|
|
|
Termination benefits were comprised of severance-related payments for all employees terminated
in connection with the 2006 restructuring program. Contract termination costs related primarily to
the termination of leases in conjunction with the consolidation of facilities. As of June 28, 2009
the 2006 restructuring program is complete. The accrued liability at June 28, 2009 and December 31,
2008 was nominal.
Impairment Charges
During the second quarter of 2009, the Company recorded a $2.3 million impairment of an
intangible asset in the Commercial Segment. See Note 5 Impairment of Goodwill and Intangible
Assets for a discussion of the charge.
Note 5 Impairment of Goodwill and Intangible Assets
On
July 20, 2009, the Company announced that it had entered into a definitive agreement to sell its Power Systems
operations to Fuel Systems Solutions, Inc. for $14.5 million. The sale is expected to be completed
in the quarter ended September 27, 2009 at which time we will report the Power Systems operations
as a discontinued operation in accordance with SFAS No. 144 Accounting for the Impairment or
Disposal of Long-Lived Assets. The final sales price for these operations is significantly below
their carrying value on the Companys balance sheet at June 28, 2009. Therefore, considering the
guidance of SFAS No. 142 we recognized a non-cash goodwill impairment charge of $25.1 million in
the quarter ended June 28, 2009 to adjust the carrying value of these operations to their estimated
fair value.
The global recession has had a more significant impact on the Companys Marine and Cargo
Container operations than initially anticipated and it appears recovery in those sectors will begin
later and at a slower rate than previously believed. As a result of the difficult market
conditions in which these reporting units are currently operating and the significant deterioration
in the operating performance of these reporting units which has accelerated in the second quarter
of 2009, the Company performed an interim review of goodwill and intangible assets in these two
reporting units during the second quarter and determined that $6.7 million of goodwill in the Cargo
Container operations and $2.3 million of indefinite lived tradenames in the Marine operations were
impaired.
12
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
In performing the goodwill impairment test, the Company estimated the fair values of these two
reporting units by a combination of (i) estimation of the discounted cash flows of each of the
reporting units based on projected earnings in the future (the income approach) and (ii) analysis
of sales of similar assets in actual transactions (the market approach). Using this methodology,
the Company determined that the entire $6.7 million of goodwill in the Cargo Container reporting
unit was impaired, but that goodwill in the Marine reporting unit was not impaired. In performing
the impairment test for the indefinite lived intangibles, the Company estimated the direct cash
flows associated with the applicable intangible assets using a relief from royalty methodology
associated with revenues projected to be generated from these intangibles. Under this methodology,
the owner of an intangible asset must determine the arms length royalty that likely would have been
charged if the owner had to license that asset from a third party. This analysis indicated that
certain tradenames in the Marine reporting unit were impaired by $2.3 million.
Note 6 Inventories
Inventories consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
June 28, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Raw materials |
|
$ |
185,145 |
|
|
$ |
185,270 |
|
Work-in-process |
|
|
59,108 |
|
|
|
55,618 |
|
Finished goods |
|
|
203,978 |
|
|
|
221,281 |
|
|
|
|
|
|
|
|
|
|
|
448,231 |
|
|
|
462,169 |
|
Less: Inventory reserve |
|
|
(37,000 |
) |
|
|
(37,516 |
) |
|
|
|
|
|
|
|
Inventories |
|
$ |
411,231 |
|
|
$ |
424,653 |
|
|
|
|
|
|
|
|
Note 7 Goodwill and other intangible assets
Changes in the carrying amount of goodwill, by operating segment, for the six months ended
June 28, 2009 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical |
|
|
Aerospace |
|
|
Commercial |
|
|
Total |
|
|
|
(Dollars in thousands) |
|
Goodwill at December 31, 2008 |
|
$ |
1,426,031 |
|
|
$ |
6,996 |
|
|
$ |
41,096 |
|
|
$ |
1,474,123 |
|
Acquisitions |
|
|
214 |
|
|
|
|
|
|
|
|
|
|
|
214 |
|
Adjustment to acquisition balance sheet |
|
|
(525 |
) |
|
|
|
|
|
|
|
|
|
|
(525 |
) |
Dispositions |
|
|
|
|
|
|
(268 |
) |
|
|
|
|
|
|
(268 |
) |
Impairment |
|
|
|
|
|
|
(6,728 |
) |
|
|
(25,145 |
) |
|
|
(31,873 |
) |
Translation adjustment |
|
|
1,685 |
|
|
|
|
|
|
|
1,068 |
|
|
|
2,753 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill at June 28, 2009 |
|
$ |
1,427,405 |
|
|
|
|
|
|
|
17,019 |
|
|
|
1,444,424 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Of the $31.9 million of goodwill impairment recognized during the second quarter of 2009,
$25.1 is attributed to the Companys Power Systems reporting unit in the Commercial Segment. The
remaining $6.7 million impairment charge represents the impairment of goodwill for the Cargo
Container reporting unit in the Aerospace Segment. See Note 5 for further discussion on the
goodwill impairment charges.
Intangible assets consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Carrying Amount |
|
|
Accumulated Amortization |
|
|
|
June 28, |
|
|
December 31, |
|
|
June 28, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Customer lists |
|
$ |
555,820 |
|
|
$ |
553,786 |
|
|
$ |
61,011 |
|
|
$ |
48,311 |
|
Intellectual property |
|
|
221,847 |
|
|
|
221,549 |
|
|
|
62,251 |
|
|
|
53,437 |
|
Distribution rights |
|
|
23,322 |
|
|
|
26,833 |
|
|
|
16,409 |
|
|
|
16,422 |
|
Trade names |
|
|
333,682 |
|
|
|
333,495 |
|
|
|
3,616 |
|
|
|
875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,134,671 |
|
|
$ |
1,135,663 |
|
|
$ |
143,287 |
|
|
$ |
119,045 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Amortization expense related to intangible assets was approximately $11.1 million and $11.8
million for the three months ended and $22.2 million and $23.5 million for the six months ended
June 28, 2009 and June 29, 2008, respectively. Estimated annual amortization expense for each of
the five succeeding years is as follows (dollars in thousands):
|
|
|
|
|
2009 |
|
$ |
45,100 |
|
2010 |
|
|
45,400 |
|
2011 |
|
|
45,100 |
|
2012 |
|
|
44,200 |
|
2013 |
|
|
42,800 |
|
Note 8 Borrowings
The carrying amount reported in the condensed consolidated balance sheet as of June 28, 2009
for long-term debt is $1,301.0 million. Using a discounted cash flow technique that incorporates a
market interest yield curve with adjustments for duration, optionality, and risk profile, the
Company has determined the fair value of its debt to be $1,192.2 million at June 28, 2009. The
Companys implied credit rating is a factor in determining the market interest yield curve.
Note 9 Financial instruments
The Company uses derivative instruments for risk management purposes. Forward rate contracts
are used to manage foreign currency transaction exposure and interest rate swaps are used to reduce
exposure to interest rate changes. In accordance with SFAS No. 133, these derivative instruments
are designated as cash flow hedges and are recorded on the balance sheet at fair market value. The
effective portion of the gains or losses on derivatives are reported as a component of other
comprehensive income and reclassified into earnings in the same period or periods during which the
hedged transaction affects earnings. Gains and losses on the derivative representing either hedge
ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in
current earnings. The fair value of the interest rate swap contracts is developed from market-based
inputs under the income approach using cash flows discounted at relevant market interest rates. The
fair value of the foreign currency forward exchange contracts represents the amount required to
enter into offsetting contracts with similar remaining maturities based on quoted market prices.
See Note 10, Fair Value Measurement for additional information.
The location and fair values of derivative instruments designated as hedging instruments under
SFAS No. 133 in the condensed consolidated balance sheet are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Values of Derivative Instruments |
|
|
|
Asset Derivatives |
|
|
Liability Derivatives |
|
|
|
As of June 28, 2009 |
|
|
|
(Dollars in thousands) |
|
|
|
|
|
|
|
Fair |
|
|
|
|
Fair |
|
|
|
Balance Sheet Location |
|
|
Value |
|
|
Balance Sheet Location |
|
Value |
|
Interest rate contracts |
|
|
|
|
|
$ |
|
|
|
Derivative liabilities current |
|
$ |
16,823 |
|
Interest rate contracts |
|
|
|
|
|
|
|
|
|
Other liabilities noncurrent |
|
|
13,962 |
|
Foreign exchange contracts |
|
Other assets current |
|
|
1,764 |
|
|
Derivative liabilities current |
|
|
3,187 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total derivatives |
|
|
|
|
|
$ |
1,764 |
|
|
|
|
$ |
33,972 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The location and amount of the gains and losses for derivatives in SFAS No. 133 cash flow
hedging relationships that were reported in other comprehensive income (OCI), accumulated other
comprehensive income (AOCI) and the condensed consolidated statement of income for the three and
six months periods ended June 28, 2009 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 28, 2009 |
|
|
|
Effective Portion |
|
|
|
Gain/(Loss) |
|
|
|
|
|
|
Recognized in |
|
|
|
|
|
|
OCI |
|
|
(Gain)/Loss Reclassified from AOCI into Income |
|
|
|
After Tax |
|
|
|
|
Pre-Tax |
|
|
|
Amount |
|
|
Location |
|
Amount |
|
|
|
(Dollars in thousands) |
|
Interest rate contracts |
|
$ |
6,164 |
|
|
Interest expense |
|
$ |
4,754 |
|
Foreign exchange contracts |
|
|
2,842 |
|
|
Net revenues |
|
|
(159 |
) |
Foreign exchange contracts |
|
|
|
|
|
Materials, labor and other product costs |
|
|
506 |
|
Foreign exchange contracts |
|
|
|
|
|
Income from discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
9,006 |
|
|
|
|
$ |
5,101 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 28, 2009 |
|
|
|
Effective Portion |
|
|
|
Gain/(Loss) |
|
|
|
|
|
|
Recognized in |
|
|
|
|
|
|
OCI |
|
|
Loss Reclassified from AOCI into Income |
|
|
|
After Tax |
|
|
|
|
Pre-Tax |
|
|
|
Amount |
|
|
Location |
|
Amount |
|
|
|
(Dollars in thousands) |
|
Interest rate contracts |
|
$ |
9,262 |
|
|
Interest expense |
|
$ |
9,111 |
|
Foreign exchange contracts |
|
|
4,525 |
|
|
Net revenues |
|
|
700 |
|
Foreign exchange contracts |
|
|
|
|
|
Materials, labor and other product costs |
|
|
2,122 |
|
Foreign exchange contracts |
|
|
|
|
|
Income from discontinued operations |
|
|
277 |
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
13,787 |
|
|
|
|
$ |
12,210 |
|
|
|
|
|
|
|
|
|
|
For the three months and six months ended June 28, 2009, there was no ineffectiveness related
to the Companys derivatives.
Note 10 Fair value measurement
The Company adopted SFAS No. 157 for financial assets and financial liabilities as of January
1, 2008, in accordance with the provisions of SFAS No. 157 and the related guidance of FSP 157-1,
FSP 157-2, FSP 157-3 and FSP 157-4. The adoption did not have an impact on the Companys financial
position and results of operations. The Company endeavors to utilize the best available information
in measuring fair value in accordance with the valuation hierarchy described below. The Company has
determined the fair value of its financial assets based on Level 1 and Level 2 inputs and the fair
value of its financial liabilities based on Level 2 inputs in accordance with the valuation
hierarchy.
Valuation Hierarchy
SFAS No. 157 establishes a valuation hierarchy of the inputs used to measure fair value. This
hierarchy prioritizes the inputs into three broad levels as follows:
Level 1 inputs quoted prices (unadjusted) in active markets for identical assets or
liabilities that the Company has ability to access at the measurement date.
15
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Level 2 inputs inputs other than quoted prices included within Level 1 that are observable
for the asset or liability, either directly or indirectly. If the asset or liability has a
specified (contractual) term, a Level 2 input must be observable for substantially the full term of
the asset or liability. Level 2 inputs include:
1. Quoted prices for similar assets or liabilities in active markets.
2. Quoted prices for identical or similar assets or liabilities in markets that are not
active.
3. Inputs other than quoted prices that are observable for the asset or liability.
4. Inputs that are derived principally from or corroborated by observable market data by
correlation or other means.
Level 3 inputs unobservable inputs for the asset or liability. Unobservable inputs may be
used to measure fair value only when observable inputs are not available. Unobservable inputs
reflect the Companys assumptions about the assumptions market participants would use in pricing
the asset or liability in achieving the fair value measurement objective of an exit price
perspective.
A financial asset or liabilitys classification within the hierarchy is determined based on
the lowest level input that is significant to the fair value measurement.
The following tables provide the financial assets and liabilities carried at fair value
measured on a recurring basis as of June 28, 2009 and June 29, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total carrying |
|
|
Quoted prices in |
|
|
Significant other |
|
|
Significant |
|
|
|
value at June 28, |
|
|
active markets |
|
|
observable inputs |
|
|
unobservable |
|
|
|
2009 |
|
|
(Level 1) |
|
|
(Level 2) |
|
|
inputs (Level 3) |
|
|
|
(Dollars in thousands) |
|
Deferred compensation
assets |
|
$ |
2,595 |
|
|
$ |
2,595 |
|
|
$ |
|
|
|
$ |
|
|
Derivative assets |
|
$ |
1,764 |
|
|
$ |
|
|
|
$ |
1,764 |
|
|
$ |
|
|
Derivative liabilities |
|
$ |
33,972 |
|
|
$ |
|
|
|
$ |
33,972 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total carrying |
|
|
Quoted prices in |
|
|
Significant other |
|
|
Significant |
|
|
|
value at June 29, |
|
|
active markets |
|
|
observable inputs |
|
|
unobservable |
|
|
|
2008 |
|
|
(Level 1) |
|
|
(Level 2) |
|
|
inputs (Level 3) |
|
|
|
(Dollars in thousands) |
|
Deferred compensation
assets |
|
$ |
3,613 |
|
|
$ |
3,613 |
|
|
$ |
|
|
|
$ |
|
|
Derivative assets |
|
$ |
1,060 |
|
|
$ |
|
|
|
$ |
1,060 |
|
|
$ |
|
|
Derivative liabilities |
|
$ |
18,712 |
|
|
$ |
|
|
|
$ |
18,712 |
|
|
$ |
|
|
Valuation Techniques
The Companys financial assets valued based upon Level 1 inputs are comprised of investments
in marketable securities held in a rabbi trust, which may be used to fund benefits under certain
deferred compensation plans. Under these deferred compensation plans, participants designate
investment options to serve as the basis for measurement of the notional value of their accounts.
The investment assets of the rabbi trust are valued using quoted market prices multiplied by the
number of shares held in the trust.
The Companys financial assets valued based upon Level 2 inputs are comprised of foreign
currency forward contracts. The Companys financial liabilities valued based upon Level 2 inputs
are comprised of an interest rate swap contract and foreign currency forward contracts. The Company
takes into account the counterparties or its own creditworthiness in measuring fair value. The
Company uses forward rate contracts to manage currency transaction exposure and interest rate swaps
to manage exposure to interest rate changes. The fair value of the interest rate swap contract is
developed from market-based inputs under the income approach using cash flows discounted at
relevant market interest rates which is then adjusted for the Companys creditworthiness using a
credit default swap rate. The fair value of the foreign currency forward exchange contracts
represents the amount required to enter into offsetting contracts with similar remaining maturities
based on quoted market prices.
16
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 11 Changes in shareholders equity
Set forth below is a reconciliation of the Companys issued common shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Shares in thousands) |
|
Common shares, beginning of period |
|
|
42,005 |
|
|
|
41,870 |
|
|
|
41,995 |
|
|
|
41,794 |
|
Shares issued under compensation plans |
|
|
|
|
|
|
62 |
|
|
|
10 |
|
|
|
138 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares, end of period |
|
|
42,005 |
|
|
|
41,932 |
|
|
|
42,005 |
|
|
|
41,932 |
|
Less: Treasury shares, end of period |
|
|
2,287 |
|
|
|
2,320 |
|
|
|
2,287 |
|
|
|
2,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding shares, end of period |
|
|
39,718 |
|
|
|
39,612 |
|
|
|
39,718 |
|
|
|
39,612 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On June 14, 2007, the Companys Board of Directors authorized the repurchase of up to $300
million of outstanding Company common stock. Repurchases of Company stock under the Board
authorization may be made from time to time in the open market and may include privately-negotiated
transactions as market conditions warrant and subject to regulatory considerations. The stock
repurchase program has no expiration date and the Companys ability to execute on the program will
depend on, among other factors, cash requirements for acquisitions, cash generation from
operations, debt repayment obligations, market conditions and regulatory requirements. In
addition, the Companys senior loan agreements limit the aggregate amount of share repurchases and
other restricted payments the Company may make to $75 million per year in the event the Companys
consolidated leverage ratio (generally consolidated total indebtedness to consolidated EBITDA,
as such terms are defined in the senior loan agreements) exceeds 3.5 to 1. Accordingly, these
provisions may limit the Companys ability to repurchase shares under this Board authorization.
Through June 28, 2009, no shares have been purchased under this Board authorization.
Basic earnings per share is computed by dividing net income by the weighted average number of
common shares outstanding during the period. Diluted earnings per share is computed in the same
manner except that the weighted average number of shares is increased for dilutive securities. The
difference between basic and diluted weighted average common shares results from the assumption
that dilutive share-based payment awards were exercised or vested at the beginning of the period. A
reconciliation of basic to diluted weighted average shares outstanding is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Shares in thousands) |
|
Basic |
|
|
39,717 |
|
|
|
39,562 |
|
|
|
39,704 |
|
|
|
39,508 |
|
Dilutive shares assumed issued |
|
|
204 |
|
|
|
269 |
|
|
|
195 |
|
|
|
262 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
39,921 |
|
|
|
39,831 |
|
|
|
39,899 |
|
|
|
39,770 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average stock options that were anti-dilutive and therefore not included in the
calculation of earnings per share were approximately 2,015 thousand and 1,749 thousand for the
three and six month periods ended June 28, 2009 and approximately 1,119 thousand and 1,029 thousand
for the three and six month periods ended June 29, 2008, respectively.
Note 12 Stock compensation plans
The Company has two stock-based compensation plans under which equity-based awards may be
made. The Companys 2000 Stock Compensation Plan (the 2000 plan) provides for the granting of
incentive and non-qualified stock options and restricted stock awards to directors, officers and
key employees. Under the 2000 plan, the Company is authorized to issue up to 4 million shares of
common stock, but no more than 800,000 of those shares may be issued as restricted stock. Options
granted under the 2000 plan have an exercise price equal to the average of the high and low sales
prices of the Companys common stock on the date of the grant, rounded to the nearest $0.25.
Generally, options granted under the 2000 plan are exercisable three to five years after the date
of the grant and expire no more than ten years after the grant. Restricted stock awards generally
vest in one to three years. During the first six
months of 2009, the Company granted non-qualified options to purchase 5,000 shares of common
stock and granted restricted stock awards representing 169,469 shares of common stock under the
2000 plan.
17
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The Companys 2008 Stock Incentive Plan (the 2008 plan) provides for the granting of various
types of equity-based awards to directors, officers and key employees. These awards include
incentive and non-qualified stock options, stock appreciation rights, stock awards and other
stock-based awards. Under the 2008 plan, the Company is authorized to issue up to 2.5 million
shares of common stock, but grants of awards other than stock options and stock appreciation rights
may not exceed 875,000 shares. Options granted under the 2008 plan have an exercise price equal to
the closing price of the Companys common stock on the date of grant. During the first six months
of 2009, the Company granted incentive and non-qualified options to purchase 452,644 shares of
common stock under the 2008 plan.
Note 13 Income taxes
The effective income tax rate for the three months ended June 28, 2009 was 51.1% compared to
33.4% for the corresponding prior year period. The effective income tax rate for the six months
ended June 28, 2009 was 34.3% compared to 37.2% for the
corresponding prior year period. The principal factors affecting comparability of the effective income tax rate for the respective
periods are the impairment losses on non-deductible goodwill of $31.9 million taken in the second
quarter of 2009 for which there was no income tax benefit, partially offset by (i) a beneficial
net impact of discrete tax charges in both the first and second quarters of 2009, including a net
reduction in income tax reserves related to the expiration of statutes of limitation for various
uncertain tax positions, the settlement of tax audits, and adjustments to previously filed tax
returns, and (ii) the impact of 2009 foreign income inclusions which will be immediately taxed in
the US.
Note 14 Pension and other postretirement benefits
The Company has a number of defined benefit pension and postretirement plans covering eligible
U.S. and non-U.S. employees. The defined benefit pension plans are noncontributory. The benefits
under these plans are based primarily on years of service and employees pay near retirement. The
Companys funding policy for U.S. plans is to contribute annually, at a minimum, amounts required
by applicable laws and regulations. Obligations under non-U.S. plans are systematically provided
for by depositing funds with trustees or by book reserves.
In 2009, the Company offered certain qualifying individuals an early retirement program. Based
on the individuals that accepted the offer the Company recognized special termination benefits of
$402 thousand in pension expense and $395 thousand in postretirement expense during the three and
six month periods ended June 28, 2009.
In 2008, the Company took the following actions with respect to its pension benefits:
Effective August 31, 2008, the Arrow Salaried plan, the Arrow Hourly plan and the
Berks plan were merged into the Teleflex Retirement Income Plan (TRIP).
On October 31, 2008, the TRIP was amended to cease future benefit accruals for all
employees, other than those subject to a collective bargaining agreement, as of December 31,
2008.
On December 15, 2008, the Company amended its Supplemental Executive Retirement
Plans (SERP) for all executives to cease future benefit accruals as of December 31, 2008. In
addition, the Company approved a plan to replace the non-qualified defined benefits provided
under the SERP with a non-qualified defined contribution arrangement under the Companys
Deferred Compensation Plan, effective January 1, 2009.
In addition, on October 31, 2008, the Companys postretirement benefit plans were amended to
eliminate future benefits for employees, other than those subject to a collective bargaining
agreement, who had not attained age 50 or whose age plus service was less than 65.
The Company and certain of its subsidiaries provide medical, dental and life insurance
benefits to pensioners and survivors. The associated plans are unfunded and approved claims are
paid from Company funds.
18
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Net benefit cost of pension and postretirement benefit plans consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension |
|
|
Other Benefits |
|
|
Pension |
|
|
Other Benefits |
|
|
|
Three Months Ended |
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in Thousands) |
|
Service cost |
|
$ |
709 |
|
|
$ |
1,330 |
|
|
$ |
284 |
|
|
$ |
247 |
|
|
$ |
1,417 |
|
|
$ |
2,656 |
|
|
$ |
567 |
|
|
$ |
494 |
|
Interest cost |
|
|
4,527 |
|
|
|
4,661 |
|
|
|
900 |
|
|
|
748 |
|
|
|
9,029 |
|
|
|
9,311 |
|
|
|
1,800 |
|
|
|
1,495 |
|
Expected return on
plan assets |
|
|
(3,694 |
) |
|
|
(5,821 |
) |
|
|
|
|
|
|
|
|
|
|
(7,377 |
) |
|
|
(11,642 |
) |
|
|
|
|
|
|
|
|
Net amortization and
deferral |
|
|
1,243 |
|
|
|
471 |
|
|
|
220 |
|
|
|
265 |
|
|
|
2,478 |
|
|
|
942 |
|
|
|
441 |
|
|
|
531 |
|
Special Termination
Costs |
|
|
402 |
|
|
|
|
|
|
|
395 |
|
|
|
|
|
|
|
402 |
|
|
|
|
|
|
|
395 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net benefit cost |
|
$ |
3,187 |
|
|
$ |
641 |
|
|
$ |
1,799 |
|
|
$ |
1,260 |
|
|
$ |
5,949 |
|
|
$ |
1,267 |
|
|
$ |
3,203 |
|
|
$ |
2,520 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 15 Commitments and contingent liabilities
Product warranty liability: The Company warrants to the original purchaser of certain of
its products that it will, at its option, repair or replace, without charge, such products if they
fail due to a manufacturing defect. Warranty periods vary by product. The Company has recourse
provisions for certain products that would enable recovery from third parties for amounts paid
under the warranty. The Company accrues for product warranties when, based on available
information, it is probable that customers will make claims under warranties relating to products
that have been sold, and a reasonable estimate of the costs (based on historical claims experience
relative to sales) can be made. Set forth below is a reconciliation of the Companys estimated
product warranty liability for the six months ended June 28, 2009 (dollars in thousands):
|
|
|
|
|
Balance December 31, 2008 |
|
$ |
17,106 |
|
Accruals for warranties issued in 2009 |
|
|
4,489 |
|
Settlements (cash and in kind) |
|
|
(4,457 |
) |
Accruals related to pre-existing warranties |
|
|
1,038 |
|
Dispositions |
|
|
(75 |
) |
Effect of translation |
|
|
247 |
|
|
|
|
|
Balance June 28, 2009 |
|
$ |
18,348 |
|
|
|
|
|
Operating leases: The Company uses various leased facilities and equipment in its
operations. The terms for these leased assets vary depending on the lease agreement. In connection
with these operating leases, the Company had residual value guarantees in the amount of
approximately $1.9 million at June 28, 2009. The Companys future payments under the operating
leases cannot exceed the minimum rent obligation plus the residual value guarantee amount. The
residual value guarantee amounts are based upon the unamortized lease values of the assets under
lease, and are payable by the Company if the Company declines to renew the leases or to exercise
its purchase option with respect to the leased assets. At June 28, 2009, the Company had no
liabilities recorded for these obligations. Any residual value guarantee amounts paid to the lessor
may be recovered by the Company from the sale of the assets to a third party.
Accounts receivable securitization program: The Company uses an accounts receivable
securitization program to gain access to credit markets with favorable interest rates and reduce
financing costs. As currently structured, accounts receivable of certain domestic subsidiaries are
sold on a non-recourse basis to a special purpose entity (SPE), which is a bankruptcy-remote
consolidated subsidiary of Teleflex Incorporated. This SPE then sells undivided interests in those
receivables to an asset backed commercial paper conduit. The conduit issues notes secured by those
interests and other assets to third party investors.
To the extent that cash consideration is received for the sale of undivided interests in the
receivables by the SPE to the conduit, it is accounted for as a sale in accordance with SFAS No.
140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of
Liabilities, as we have relinquished control of the receivables. Accordingly, undivided interests
in accounts receivable sold to the commercial paper conduit under these transactions are excluded
from accounts receivables, net in the accompanying condensed consolidated balance sheets. The
interests for which cash consideration is not received from the conduit are retained by the SPE and
remain in accounts receivable in the accompanying condensed consolidated balance sheets.
19
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The interests in receivables sold and the interest in receivables retained by the SPE are
carried at face value, which is due to the short-term nature of our accounts receivable. The
special purpose entity has received cash consideration of $39.7 million and $39.7
million for the interests in the accounts receivable it has sold to the commercial paper
conduit at June 28, 2009 and December 31, 2008, respectively. No gain or loss is recorded upon sale
as fee charges from the commercial paper conduit are based upon a floating yield rate and the
period the undivided interests remain outstanding. Fee charges from the commercial paper conduit
are accrued at the end of each month. If the Company defaults under the accounts receivable
securitization program, the commercial paper conduit is entitled to receive collections on
receivables owned by the SPE in satisfaction of the amount of cash consideration paid to the SPE by
the commercial paper conduit. The assets of the SPE are not available to satisfy the obligations of
Teleflex or any of its other subsidiaries.
Information regarding the outstanding balances related to the SPEs interests in accounts
receivables sold or retained as of June 28, 2009 is as follows:
|
|
|
|
|
|
|
(Dollars in millions) |
|
Interests in receivables sold outstanding (1) |
|
$ |
39.7 |
|
Interests in receivables retained, net of allowance for doubtful accounts |
|
$ |
88.5 |
|
|
|
|
(1) |
|
Deducted from accounts receivables, net in the condensed consolidated balance sheets. |
The delinquency ratio for the qualifying receivables represented 4.4% of the total qualifying
receivables as of June 28, 2009.
The following table summarizes the activity related to our interests in accounts receivable
sold for the three and six month periods ended June 28, 2009:
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Six Months |
|
|
|
Ended June 28, |
|
|
Ended June 28, |
|
|
|
2009 |
|
|
2009 |
|
|
|
(Dollars in millions) |
|
Proceeds from the sale of interest in accounts receivable |
|
$ |
35.0 |
|
|
$ |
35.0 |
|
Fees and charges (1) |
|
$ |
0.3 |
|
|
$ |
0.6 |
|
|
|
|
(1) |
|
Recorded in interest expense in the condensed consolidated statement of
operations. |
Other fee charges related to the sale of receivables to the commercial paper conduit for the
three and six month periods ended June 28, 2009 were not material.
The Company continues to service the receivables after they are sold to the conduit pursuant
to servicing agreements with the SPE. No servicing asset is recorded at the time of sale because we
do not receive any servicing fees from third parties or other income related to the servicing of
the receivables. The Company does not record any servicing liability at the time of the sale as the
receivables collection period is relatively short and the costs of servicing the receivables sold
over the servicing period are insignificant. Servicing costs are recognized as incurred over the
servicing period.
Environmental: The Company is subject to contingencies as a result of environmental laws
and regulations that in the future may require the Company to take further action to correct the
effects on the environment of prior disposal practices or releases of chemical or petroleum
substances by the Company or other parties. Much of this liability results from the U.S.
Comprehensive Environmental Response, Compensation and Liability Act (CERCLA), often referred to
as Superfund, the U.S. Resource Conservation and Recovery Act (RCRA) and similar state laws.
These laws require the Company to undertake certain investigative and remedial activities at sites
where the Company conducts or once conducted operations or at sites where Company-generated waste
was disposed.
Remediation activities vary substantially in duration and cost from site to site. These
activities, and their associated costs, depend on the mix of unique site characteristics, evolving
remediation technologies, diverse regulatory agencies and enforcement policies, as well as the
presence or absence of other potentially responsible parties. At June 28, 2009, the Companys
condensed consolidated balance sheet included an accrued liability of approximately $9.5 million
relating to these matters. Considerable uncertainty exists with respect to these costs and, if
adverse changes in circumstances occur, potential liability may exceed the amount accrued as of
June 28, 2009. The time frame over which the accrued amounts may be paid out, based on past
history, is estimated to be 15-20 years.
20
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Regulatory matters: On October 11, 2007, the Companys subsidiary, Arrow International,
Inc. (Arrow), received a corporate warning letter from the U.S. Food and Drug Administration
(FDA). The letter cites three site-specific warning letters issued by the FDA in 2005 and
subsequent inspections performed from June 2005 to February 2007 at Arrows facilities in the
United States. The
letter expresses concerns with Arrows quality systems, including complaint handling,
corrective and preventive action, process and design validation, inspection and training
procedures. It also advises that Arrows corporate-wide program to evaluate, correct and prevent
quality system issues has been deficient. Limitations on pre-market approvals and certificates for
foreign governments had previously been imposed on Arrow based on prior inspections and the
corporate warning letter did not impose additional sanctions that are expected to have a material
financial impact on the Company.
In connection with its acquisition of Arrow, completed on October 1, 2007, the Company
developed an integration plan that included the commitment of significant resources to correct
these previously-identified regulatory issues and further improve overall quality systems. Senior
management officials from the Company have met with FDA representatives, and a comprehensive
written corrective action plan was presented to FDA in late 2007. The Company has completed
implementation of the corrective actions under the plan and is awaiting re-inspection by the FDA.
While the Company believes it has substantially remediated these issues through the corrective
actions taken to date, there can be no assurances that these issues have been resolved to the
satisfaction of the FDA. If the Companys remedial actions are not satisfactory to the FDA, the
Company may have to devote additional financial and human resources to its efforts, and the FDA may
take further regulatory actions against the Company, including, but not limited to, seizing its
product inventory, obtaining a court injunction against further marketing of the Companys
products, assessing civil monetary penalties or imposing a consent decree on us.
Litigation: The Company is a party to various lawsuits and claims arising in the normal
course of business. These lawsuits and claims include actions involving product liability,
intellectual property, employment and environmental matters. Based on information currently
available, advice of counsel, established reserves and other resources, the Company does not
believe that any such actions are likely to be, individually or in the aggregate, material to its
business, financial condition, results of operations or liquidity. However, in the event of
unexpected further developments, it is possible that the ultimate resolution of these matters, or
other similar matters, if unfavorable, may be materially adverse to the Companys business,
financial condition, results of operations or liquidity. Legal costs such as outside counsel fees
and expenses are charged to expense in the period incurred.
Other: The Company has various purchase commitments for materials, supplies and items of
permanent investment incident to the ordinary conduct of business. On average, such commitments are
not at prices in excess of current market.
21
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 16 Business segment information
Information about continuing operations by business segment is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Segment data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical |
|
$ |
363,928 |
|
|
$ |
384,335 |
|
|
$ |
704,470 |
|
|
$ |
758,392 |
|
Aerospace |
|
|
36,961 |
|
|
|
65,733 |
|
|
|
80,690 |
|
|
|
132,021 |
|
Commercial |
|
|
82,170 |
|
|
|
109,610 |
|
|
|
167,574 |
|
|
|
211,375 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment net revenues |
|
$ |
483,059 |
|
|
$ |
559,678 |
|
|
$ |
952,734 |
|
|
$ |
1,101,788 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical |
|
$ |
78,575 |
|
|
$ |
70,652 |
|
|
$ |
148,768 |
|
|
$ |
141,564 |
|
Aerospace |
|
|
1,020 |
|
|
|
7,657 |
|
|
|
4,057 |
|
|
|
12,585 |
|
Commercial |
|
|
3,171 |
|
|
|
9,460 |
|
|
|
7,832 |
|
|
|
12,307 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating profit(1) |
|
|
82,766 |
|
|
|
87,769 |
|
|
|
160,657 |
|
|
|
166,456 |
|
Less: Corporate expenses |
|
|
11,013 |
|
|
|
11,157 |
|
|
|
21,780 |
|
|
|
24,165 |
|
Net loss on sales of businesses and assets |
|
|
|
|
|
|
|
|
|
|
2,597 |
|
|
|
18 |
|
Goodwill impairment |
|
|
31,873 |
|
|
|
|
|
|
|
31,873 |
|
|
|
|
|
Restructuring and other impairment charges |
|
|
6,166 |
|
|
|
2,591 |
|
|
|
8,629 |
|
|
|
11,447 |
|
Noncontrolling interest |
|
|
(302 |
) |
|
|
(259 |
) |
|
|
(538 |
) |
|
|
(446 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before
interest and
taxes |
|
$ |
34,016 |
|
|
$ |
74,280 |
|
|
$ |
96,316 |
|
|
$ |
131,272 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 28, 2009 |
|
|
December 31, 2008 |
|
|
|
(Dollars in thousands) |
|
Identifiable assets(2):
|
|
|
|
|
|
|
|
|
Medical |
|
$ |
3,124,637 |
|
|
$ |
3,135,360 |
|
Aerospace |
|
|
142,197 |
|
|
|
244,994 |
|
Commercial |
|
|
152,860 |
|
|
|
215,894 |
|
Corporate |
|
|
350,380 |
|
|
|
322,286 |
|
|
|
|
|
|
|
|
|
|
$ |
3,770,074 |
|
|
$ |
3,918,534 |
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Segment operating profit includes a segments net revenues reduced by its
materials, labor and other product costs along with the segments selling, engineering
and administrative expenses and noncontrolling interest. Unallocated corporate expenses,
(gain) loss on sales of assets, restructuring and other impairment charges, interest
income and expense and taxes on income are excluded from the measure. |
|
(2) |
|
Identifiable assets do not
include assets held for sale of $8.7 million and $8.2 million in
2009 and 2008, respectively. |
Note 17 Divestiture-related activities
As dispositions occur in the normal course of business, gains or losses on the sale of such
businesses are recognized in the income statement line item Net loss on sales of businesses and
assets.
22
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The following table provides the amount of Net loss on sales of businesses and assets for the
three and six month periods ended June 28, 2009 and June 29, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Net loss on sales of businesses and assets |
|
$ |
|
|
|
$ |
|
|
|
$ |
2,597 |
|
|
$ |
18 |
|
During the first quarter of 2009, the Company realized a loss of $2.6 million on the sale of a
product line in its Marine business.
Assets Held for Sale
Assets held for sale at June 28, 2009 and December 31, 2008 consists of four buildings which
the Company is actively marketing. During the second quarter of 2009, the Company sold two
buildings at approximately net book value and added two new properties to assets held for sale.
Discontinued Operations
On March 20, 2009, the Company completed the sale of its 51 percent share of Airfoil
Technologies International Singapore Pte. Ltd. (ATI Singapore) to GE Pacific Private Limited
for $300 million in cash. ATI Singapore, which provides engine repair products and services for
critical components of flight turbines, was part of a joint venture between General Electric
Company (GE) and the Company. The Company and GE are also parties to an agreement that will
permit the Company to transfer its ownership interest in the remaining ATI business (together with
ATI Singapore, the ATI Business) to GE by the end of 2009.
In the second quarter of 2008, the Company refined its estimates for the post-closing
adjustments based on the provisions of the Purchase Agreement with Kongsberg Automotive Holdings on
the sale of the Companys business units that design and manufacture automotive and industrial
driver controls, motion systems and fluid handling systems (the GMS businesses) in 2007. Also
during the second quarter of 2008, the Company recorded a charge for the settlement of a
contingency related to the sale of the GMS businesses. These activities resulted in a decrease in
the gain on sale of the GMS businesses and are reported in discontinued operations as a loss of
$4.8 million, with related taxes of $2.0 million.
The Companys condensed consolidated statement of income for the three and six month periods
ended June 28, 2009 and June 29, 2008 has been retrospectively adjusted to reflect the operations
of the ATI Business as discontinued in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Net revenues |
|
$ |
|
|
|
$ |
64,407 |
|
|
$ |
67,721 |
|
|
$ |
126,817 |
|
Costs and other expenses |
|
|
|
|
|
|
45,467 |
|
|
|
45,533 |
|
|
|
92,682 |
|
(Gain) loss on disposition |
|
|
|
|
|
|
4,808 |
|
|
|
(275,787 |
) |
|
|
4,808 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued
operations before income
taxes |
|
|
|
|
|
|
14,132 |
|
|
|
297,975 |
|
|
|
29,327 |
|
Provision for income taxes |
|
|
(181 |
) |
|
|
(1,036 |
) |
|
|
98,837 |
|
|
|
(630 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations |
|
|
181 |
|
|
|
15,168 |
|
|
|
199,138 |
|
|
|
29,957 |
|
Less: Income from discontinued
operations attributable to
noncontrolling interest |
|
|
|
|
|
|
8,839 |
|
|
|
9,860 |
|
|
|
15,706 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued
operations attributable to common
shareholders |
|
$ |
181 |
|
|
$ |
6,329 |
|
|
$ |
189,278 |
|
|
$ |
14,251 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23
TELEFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Concluded)
Net assets and liabilities sold as of March 20, 2009 in relation to the ATI Business were
comprised of the following:
|
|
|
|
|
|
|
(Dollars in thousands) |
|
|
|
|
|
|
Net assets |
|
$ |
101,052 |
|
|
|
|
|
|
Net liabilities |
|
|
(67,474 |
) |
|
|
|
|
|
|
|
|
|
|
|
$ |
33,578 |
|
|
|
|
|
Note 18 Subsequent Event
On July 20, 2009 the Company announced that it had signed a definitive agreement to sell its
Power Systems business (Power) to Fuel Systems Solutions, Inc. Teleflex will receive cash
proceeds of $14.5 million. The transaction is subject to certain customary closing conditions and
is expected to be completed in the quarter ended September 27, 2009 at which time Power will be
reflected in the Companys future consolidated financial statements as a discontinued operation.
The final sales price for Power was below the carrying value on the Companys balance sheet at
June 28, 2009. Therefore, the Company recognized a non-cash, non-tax deductible goodwill impairment
charge of approximately $25.1 million to adjust the carrying value of these operations to their
estimated fair value.
24
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
All statements made in this Quarterly Report on Form 10-Q, other than statements of historical
fact, are forward-looking statements. The words anticipate, believe, estimate, expect,
intend, may, plan, will, would, should, guidance, potential, continue, project,
forecast, confident, prospects, and similar expressions typically are used to identify
forward-looking statements. Forward-looking statements are based on the then-current expectations,
beliefs, assumptions, estimates and forecasts about our business and the industry and markets in
which we operate. These statements are not guarantees of future performance and are subject to
risks, uncertainties and assumptions which are difficult to predict. Therefore, actual outcomes and
results may differ materially from what is expressed or implied by these forward-looking statements
due to a number of factors, including changes in business relationships with and purchases by or
from major customers or suppliers, including delays or cancellations in shipments; demand for and
market acceptance of new and existing products; our ability to integrate acquired businesses into
our operations, realize planned synergies and operate such businesses profitably in accordance with
expectations; our ability to effectively execute our restructuring programs; competitive market
conditions and resulting effects on revenues and pricing; increases in raw material costs that
cannot be recovered in product pricing; and global economic factors, including currency exchange
rates and interest rates; difficulties entering new markets; and general economic conditions. For
a further discussion of the risks relating to our business, see Item 1A of our Annual Report on
Form 10-K for the fiscal year ended December 31, 2008. We expressly disclaim any obligation to
update these forward-looking statements, except as otherwise specifically stated by us or as
required by law or regulation.
Overview
Teleflex strives to maintain a portfolio of businesses that provide consistency of
performance, improved profitability and sustainable growth. Over the past several years, we
significantly changed the composition of our portfolio through acquisitions and divestitures to
improve margins, reduce cyclicality and focus our resources on the development of our core
businesses.
On March 20, 2009, we completed the sale of our 51 percent share of Airfoil Technologies
International Singapore Pte. Ltd. (ATI Singapore) to GE Pacific Private Limited for $300
million in cash. We recognized a gain of approximately $179 million, net of $97 million of taxes,
in discontinued operations. We are also party to an agreement with General Electric Company (GE)
that will permit us to transfer our ownership interest in the remaining ATI business (together with
ATI Singapore, the ATI Business) to GE by the end of 2009. We used $240 million of the proceeds
to repay long-term debt. (See Note 17 to our condensed consolidated financial statements included
in this report for discussion of discontinued operations).
We are focused on achieving consistent and sustainable growth through our internal growth
initiatives which include the development of new products, expansion of market share, moving
existing products into new geographies, and through selected acquisitions which enhance or expedite
our development initiatives and our ability to increase market share. We continually evaluate the
composition of the portfolio of our businesses to ensure alignment with our overall objectives.
The Medical, Aerospace and Commercial segments comprised 74%, 8% and 18% of our revenues,
respectively, for the six months ended June 28, 2009 and comprised 69%, 12% and 19% of our
revenues, respectively, for the same period in 2008.
Critical Accounting Estimates
Preparation of our financial statements requires management to make estimates and assumptions
that affect the reported amounts of assets, liabilities, revenues and expenses. We believe the most
complex and sensitive judgments, because of their significance to the Consolidated Financial
Statements, result primarily from the need to make estimates about the effects of matters that are
inherently uncertain. Managements Discussion and Analysis and Note 1 to the Consolidated Financial
Statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2008
describe the significant accounting estimates and policies used in preparation of the Consolidated
Financial Statements. Actual results in these areas could differ from managements estimates. We
have not identified any new critical accounting estimates during the first six months of 2009.
Results of Operations
Discussion of growth from acquisitions reflects the impact of a purchased company for up to
twelve months beyond the date of acquisition. Activity beyond the initial twelve months is
considered core growth. Core growth excludes the impact of translating the results of international
subsidiaries at different currency exchange rates from year to year and the comparable activity of
divested companies within the most recent twelve-month period.
25
The following comparisons exclude the operations of the ATI Business which have been presented
in our consolidated financial results as discontinued operations (see Note 17 to our condensed
consolidated financial statements included in this report for discussion of discontinued
operations).
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Net revenues |
|
$ |
483.1 |
|
|
$ |
559.7 |
|
|
$ |
952.7 |
|
|
$ |
1,101.8 |
|
Net revenues for the second quarter of 2009 decreased approximately 14% to $483.1 million from
$559.7 million in 2008. Core revenues for the quarter declined 8% , and foreign currency
translation caused an additional 5% of the decline in revenue. The disposition of a product line in
the Commercial Segment during the first quarter of 2009 accounted for the remaining 1% of the
decline in revenues. Core revenues were down in the Aerospace Segment (36%), as air cargo traffic
continues to be well below 2008 levels and in the Commercial Segment (18%), as weak global economic
conditions continue to negatively impact the markets served by our products in this segment. Core
revenues in the Medical Segment were essentially unchanged from the second quarter of 2008 as
slightly higher sales of surgical and cardiac care products were offset by lower sales of critical
care products and orthopedic devices sold to medical original equipment manufacturers, or OEMs.
Net revenues for the first six months of 2009 decreased approximately 13% to $952.7 million
from $1,101.8 million in 2008. Revenues from core business caused 8% of the decline in revenue,
while foreign currency translation caused 5% of the decline. We experienced declines in core
revenue in each of our three segments, Medical (1%), Aerospace (32%) and Commercial (16%). Weak
global economic conditions have negatively impacted markets served by our Aerospace and Commercial
Segments throughout 2009 and core growth in the Medical Segment was negatively impacted by
distributor inventory reductions in the first quarter of 2009, lower demand for respiratory care
products in North America due to a less severe flu season compared to 2008 and a decline in
orthopedic devices sold to medical OEMs.
Gross profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Gross profit |
|
$ |
206.0 |
|
|
$ |
234.3 |
|
|
$ |
402.1 |
|
|
$ |
447.8 |
|
Percentage of sales |
|
|
42.6 |
% |
|
|
41.9 |
% |
|
|
42.2 |
% |
|
|
40.6 |
% |
Gross profit as a percentage of revenues for second quarter of 2009 increased to 42.6% from
41.9% in 2008. The principal factor impacting the overall increase was the higher percentage of
Medical revenues. Gross profit as a percentage of revenue was higher
in the Medical Segment, but
lower in the Aerospace and Commercial Segments.
Gross profit as a percentage of revenues for the first six months of 2009 increased to 42.2%
from 40.6% for the same period in 2008. The principal factor impacting the overall increase was a
higher percentage of Medical revenues and a $7 million fair value adjustment to inventory in the
first quarter of 2008 related to inventory acquired in the Arrow acquisition, which did not recur
in 2009. Gross profit as a percentage of revenue for the first six months of 2009 was higher in
the Medical Segment, lower in the Commercial Segment and unchanged in
the Aerospace Segment
compared to the same period of 2008.
Selling, engineering and administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Selling, engineering and administrative |
|
$ |
134.0 |
|
|
$ |
157.4 |
|
|
$ |
262.7 |
|
|
$ |
305.0 |
|
Percentage of sales |
|
|
27.7 |
% |
|
|
28.1 |
% |
|
|
27.6 |
% |
|
|
27.7 |
% |
26
Selling, engineering and administrative expenses (operating expenses) as a percentage of
revenues were 27.7% for the second quarter of 2009 compared to 28.1% for 2008. The reduction in
these costs was principally the result of movements in currency exchange rates of approximately $8
million and cost reduction initiatives, including restructuring and integration activities in
connection with the Arrow acquisition, which reduced these expenses by approximately $15 million.
Selling, engineering and administrative expenses as a percentage of revenues were 27.6% for
the first six months of 2009 which is essentially the same percentage as in the first six months of
2008. The reduction in these costs was principally the result of movements in currency exchange
rates of approximately $13 million and cost reduction initiatives, including restructuring and
integration activities in connection with the Arrow acquisition and the 2008 Commercial Segment
restructuring program, which reduced these expenses by approximately $29 million.
Interest expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Interest expense |
|
$ |
22.0 |
|
|
$ |
31.4 |
|
|
$ |
47.4 |
|
|
$ |
62.5 |
|
Average interest rate on debt |
|
|
5.9 |
% |
|
|
6.2 |
% |
|
|
5.8 |
% |
|
|
6.3 |
% |
Interest expense decreased in the second quarter of 2009 compared to the same period of 2008
due to a reduction of approximately $375 million in average outstanding debt during the period and
lower interest rates. For the first six months of 2009 average outstanding debt was approximately
$260 million lower compared to the corresponding period of 2008.
Taxes on income from continuing operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Effective income tax rate |
|
|
51.1 |
% |
|
|
33.4 |
% |
|
|
34.3 |
% |
|
|
37.2 |
% |
The principal factors affecting comparability of the effective income tax rate for the
respective periods are the impairment losses on non-deductible goodwill of $31.9 million taken in
the second quarter of 2009 for which there was no income tax benefit, partially offset by (i) a
beneficial net impact of discrete tax charges in both the first and second quarters of 2009,
including a net reduction in income tax reserves related to the expiration of statutes of
limitation for various uncertain tax positions, the settlement of tax audits, and adjustments to
previously filed tax returns, and (ii) the impact of 2009 foreign income inclusions which will be
immediately taxed in the US.
Goodwill impairment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Commercial Segment |
|
$ |
25,145 |
|
|
$ |
|
|
|
$ |
25,145 |
|
|
$ |
|
|
Aerospace Segment |
|
|
6,728 |
|
|
|
|
|
|
|
6,728 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill impairment |
|
$ |
31,873 |
|
|
$ |
|
|
|
$ |
31,873 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On
July 20, 2009 we announced that we had entered into a definitive agreement to sell our Power Systems operations for
$14.5 million which is significantly less than its carrying value on the Companys balance sheet at
June 28, 2009. Therefore, considering the guidance of SFAS No. 142 we recognized a non-cash
goodwill impairment charge of $25.1 million in the quarter ended June 28, 2009 to adjust the
carrying value of these operations to their estimated fair value.
27
The global recession has had a more significant impact on the Companys Marine and Cargo
Container operations than initially anticipated and it appears recovery in those sectors will begin
later and at a slower rate than previously believed. As a result of the difficult market
conditions in which these reporting units are currently operating and the significant deterioration
in the operating performance of these reporting units which has accelerated in the second quarter
of 2009, the Company performed an interim review of goodwill and intangible assets in these two
reporting units during the second quarter and determined that $6.7 million of goodwill in the Cargo
Container operations was impaired.
We will continue to monitor and evaluate the carrying values of our goodwill. If market and
economic conditions or our units business performance deteriorates significantly, this could
result in our performance of additional interim impairment reviews in the future quarters. Any such
impairment reviews could result in recognition of a goodwill impairment charge in 2009 or
thereafter.
Restructuring and other impairment charges
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 28, |
|
|
June 29, |
|
|
June 28, |
|
|
June 29, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
2008 Commercial Segment program |
|
$ |
917 |
|
|
$ |
|
|
|
$ |
2,055 |
|
|
$ |
|
|
2007 Arrow integration program |
|
|
2,775 |
|
|
|
2,734 |
|
|
|
4,100 |
|
|
|
10,780 |
|
2006 restructuring program |
|
|
|
|
|
|
(143 |
) |
|
|
|
|
|
|
667 |
|
Impairment charges |
|
|
2,474 |
|
|
|
|
|
|
|
2,474 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring and other impairment charges |
|
$ |
6,166 |
|
|
$ |
2,591 |
|
|
$ |
8,629 |
|
|
$ |
11,447 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In December 2008, we began certain restructuring initiatives that affect the Commercial
Segment. These initiatives involve the consolidation of operations and a related reduction in
workforce at three of our facilities in Europe and North America. We determined to undertake these
initiatives to improve operating performance and to better leverage our existing resources in light
of expected continued weakness in the marine and industrial markets. These costs amounted to
approximately $0.9 million and $2.1 million during the three and six months ended June 28, 2009,
respectively. As of June 28, 2009, we have completed the 2008 Commercial Segment restructuring
program. We expect to realize annual pre-tax savings of between $3.5 $4.5 million in 2010.
In connection with the acquisition of Arrow in 2007, we formulated a plan related to the
future integration of Arrow and our other Medical businesses. The integration plan focuses on the
closure of Arrow corporate functions and the consolidation of manufacturing, sales, marketing, and
distribution functions in North America, Europe and Asia. Costs related to actions that affect
employees and facilities of Arrow have been included in the allocation of the purchase price of
Arrow. Costs related to actions that affect employees and facilities of Teleflex are charged to
earnings and included in restructuring and impairment charges within the consolidated statement of
operations. These costs amounted to approximately $2.8 million and $4.1 million during the three
and six months ended June 28, 2009, respectively. As of June 28, 2009, we estimate that, for the
remainder of 2009 and 2010, the aggregate of future restructuring and impairment charges that we
will incur in connection with the Arrow integration plan are approximately $9.9 $12.3 million. Of
this amount, $3.5 $4.5 million relates to employee termination costs, $0.8 $1.0 million relates
to facility closure costs, $5.5 $6.5 million relates to contract termination costs associated
with the termination of leases and certain distribution agreements and $0.1 $0.3 million relates
to other restructuring costs. We also have incurred restructuring related costs in the Medical
Segment which do not qualify for classification as restructuring costs. In 2009 these costs
amounted to $1.1 million and are reported in the Medical Segments operating results in selling,
engineering and administrative expenses. We expect to have realized annual pre-tax savings of
between $70 $75 million in 2010 when these integration and restructuring actions are complete.
In June 2006, we began certain restructuring initiatives that affected all three of our
operating segments. These initiatives involved the consolidation of operations and a related
reduction in workforce at several of our facilities in Europe and North America. We took these
initiatives as a means to improving operating performance and to better leverage our existing
resources. These activities are now complete.
During the second quarter of 2009, we recorded a $2.3 million impairment of an intangible
asset in the Commercial Segment.
28
For additional information regarding our restructuring programs, see Note 4 to our condensed
consolidated financial statements included in this report.
Segment Reviews
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
|
|
|
|
|
|
|
|
% |
|
|
|
|
|
|
|
|
|
|
% |
|
|
|
June 28, |
|
|
June 29, |
|
|
Increase/ |
|
|
June 28, |
|
|
June 29, |
|
|
Increase/ |
|
|
|
2009 |
|
|
2008 |
|
|
(Decrease) |
|
|
2009 |
|
|
2008 |
|
|
(Decrease) |
|
|
|
(Dollars in thousands) |
|
|
Medical |
|
$ |
363,928 |
|
|
$ |
384,335 |
|
|
|
(5 |
) |
|
$ |
704,470 |
|
|
$ |
758,392 |
|
|
|
(7 |
) |
Aerospace |
|
|
36,961 |
|
|
|
65,733 |
|
|
|
(44 |
) |
|
|
80,690 |
|
|
|
132,021 |
|
|
|
(39 |
) |
Commercial |
|
|
82,170 |
|
|
|
109,610 |
|
|
|
(25 |
) |
|
|
167,574 |
|
|
|
211,375 |
|
|
|
(21 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment net revenues |
|
$ |
483,059 |
|
|
$ |
559,678 |
|
|
|
(14 |
) |
|
$ |
952,734 |
|
|
$ |
1,101,788 |
|
|
|
(13 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical |
|
$ |
78,575 |
|
|
$ |
70,652 |
|
|
|
11 |
|
|
$ |
148,768 |
|
|
$ |
141,564 |
|
|
|
5 |
|
Aerospace |
|
|
1,020 |
|
|
|
7,657 |
|
|
|
(87 |
) |
|
|
4,057 |
|
|
|
12,585 |
|
|
|
(68 |
) |
Commercial |
|
|
3,171 |
|
|
|
9,460 |
|
|
|
(66 |
) |
|
|
7,832 |
|
|
|
12,307 |
|
|
|
(36 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating
profit
(1) |
|
$ |
82,766 |
|
|
$ |
87,769 |
|
|
|
(6 |
) |
|
$ |
160,657 |
|
|
$ |
166,456 |
|
|
|
(3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See Note 16 of our condensed consolidated financial statements for a reconciliation of
segment operating profit to income from continuing operations before interest and taxes. |
The percentage decreases in net revenues during the three and six month periods ended June 28,
2009 compared to the same period in 2008 are due to the following factors:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Increase / (Decrease) |
|
|
|
2009 vs. 2008 |
|
|
|
Medical |
|
|
Aerospace |
|
|
Commercial |
|
|
Total |
|
|
|
Three |
|
|
Six |
|
|
Three |
|
|
Six |
|
|
Three |
|
|
Six |
|
|
Three |
|
|
Six |
|
|
|
Months |
|
|
Months |
|
|
Months |
|
|
Months |
|
|
Months |
|
|
Months |
|
|
Months |
|
|
Months |
|
Core growth |
|
|
|
|
|
|
(1 |
) |
|
|
(36 |
) |
|
|
(32 |
) |
|
|
(18 |
) |
|
|
(16 |
) |
|
|
(8 |
) |
|
|
(8 |
) |
Currency impact |
|
|
(5 |
) |
|
|
(6 |
) |
|
|
(8 |
) |
|
|
(7 |
) |
|
|
(3 |
) |
|
|
(3 |
) |
|
|
(5 |
) |
|
|
(5 |
) |
Dispositions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4 |
) |
|
|
(2 |
) |
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total change |
|
|
(5 |
) |
|
|
(7 |
) |
|
|
(44 |
) |
|
|
(39 |
) |
|
|
(25 |
) |
|
|
(21 |
) |
|
|
(14 |
) |
|
|
(13 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following is a discussion of our segment operating results.
Comparison of the three and six month periods ended June 28, 2009 and June 29, 2008
Medical
Medical Segment net revenues declined 5% in the second quarter of 2009 to $363.9 million, from
$384.3 million in the same period last year. Foreign currency fluctuations caused all the revenue
decline as core revenues were essentially flat compared to the second quarter of 2008. Core
revenue was higher in the North American, European and Asia/Latin American surgical product groups,
but offset by declines in the OEM orthopedic instrumentation product group.
Net revenues for the first six months of 2009 declined 7% compared to the same period of 2008
to $704.5 million, from $758.4 million in the same period in 2008. Foreign currency fluctuations caused 6%
of this decrease while core revenue declined 1% during the first six months compared to the same
period in 2008. The decline in core revenue was predominantly in the North American critical care
market in the first quarter of 2009 and in the OEM orthopedic instrumentation product group.
29
Information regarding net sales by product group is provided in the following tables. Certain
reclassifications within product groups have been made to 2008 amounts to conform to the current
year presentation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
% Increase/ (Decrease) |
|
|
|
June 28, |
|
|
June 29, |
|
|
Core |
|
|
Currency |
|
|
Total |
|
|
|
2009 |
|
|
2008 |
|
|
Growth |
|
|
Impact |
|
|
Change |
|
|
|
(Dollars in millions) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Critical Care |
|
$ |
230.9 |
|
|
$ |
246.3 |
|
|
|
|
|
|
|
(6 |
) |
|
|
(6 |
) |
Surgical |
|
|
73.1 |
|
|
|
74.4 |
|
|
|
5 |
|
|
|
(7 |
) |
|
|
(2 |
) |
Cardiac Care |
|
|
19.3 |
|
|
|
19.0 |
|
|
|
7 |
|
|
|
(5 |
) |
|
|
2 |
|
OEM |
|
|
37.7 |
|
|
|
40.8 |
|
|
|
(6 |
) |
|
|
(2 |
) |
|
|
(8 |
) |
Other |
|
|
2.9 |
|
|
|
3.8 |
|
|
|
(12 |
) |
|
|
(12 |
) |
|
|
(24 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net sales |
|
$ |
363.9 |
|
|
$ |
384.3 |
|
|
|
|
|
|
|
(5 |
) |
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
% Increase/ (Decrease) |
|
|
|
June 28, |
|
|
June 29, |
|
|
Core |
|
|
Currency |
|
|
Total |
|
|
|
2009 |
|
|
2008 |
|
|
Growth |
|
|
Impact |
|
|
Change |
|
|
|
(Dollars in millions) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Critical Care |
|
$ |
449.0 |
|
|
$ |
490.0 |
|
|
|
(3 |
) |
|
|
(5 |
) |
|
|
(8 |
) |
Surgical |
|
|
142.1 |
|
|
|
147.3 |
|
|
|
3 |
|
|
|
(7 |
) |
|
|
(4 |
) |
Cardiac Care |
|
|
34.7 |
|
|
|
37.2 |
|
|
|
(1 |
) |
|
|
(6 |
) |
|
|
(7 |
) |
OEM |
|
|
71.9 |
|
|
|
77.1 |
|
|
|
(5 |
) |
|
|
(2 |
) |
|
|
(7 |
) |
Other |
|
|
6.8 |
|
|
|
6.8 |
|
|
|
14 |
|
|
|
(14 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net sales |
|
$ |
704.5 |
|
|
$ |
758.4 |
|
|
|
(1 |
) |
|
|
(6 |
) |
|
|
(7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical Segment net revenues for the six months ended June 28, 2009 and June 29, 2008,
respectively, by geographic location were as follows:
|
|
|
|
|
|
|
|
|
|
|
2009 |
|
|
2008 |
|
North America |
|
|
54 |
% |
|
|
52 |
% |
Europe, Middle East and Africa |
|
|
36 |
% |
|
|
38 |
% |
Asia and Latin America |
|
|
10 |
% |
|
|
10 |
% |
The decrease in critical care product sales during the second quarter of 2009 compared to the
same period in 2008 was entirely due to the 6% decrease in currency exchange rates as core revenue
of critical care products was essentially unchanged from the same period in 2008. For the first
six months of 2009, currency exchange rates caused 5% of the revenue decline and 3% was due to a
decline in core revenue principally due to distributor inventory reductions in the first quarter of
2009 and, with regards to our respiratory care products, a less severe flu season in the first
quarter of 2009 compared to 2008.
Surgical product core revenue increased approximately 5% during the second quarter of 2009 in
North America, Europe and Asia / Latin America, combined, but was more than offset by the 7%
decline in foreign currency rate movements. For the first six months of 2009, surgical product core
revenue increased 3% principally due to higher sales in Europe and Asia/Latin America, but was more
than offset by a 7% decline in currency exchange rates.
Sales credits issued to customers and the related delay in shipments of replacement products
in connection with a voluntary recall of certain intra aortic balloon pump catheters during the
first quarter of 2009 was the principal factor in the lack of growth in sales of cardiac care
products during the first six months of 2009 compared to the same period of 2008.
Sales to OEMs declined 8% in the second quarter of 2009 and 7% for the first six months of
2009. These declines were largely attributable to lower sales of orthopedic instrumentation
products due to customer inventory rebalancing and a reduction in new product launches by OEM
customers.
Operating profit in the Medical Segment increased 11%, from $70.7 million in the second
quarter of 2008 to $78.6 million during the second quarter of 2009. The negative impact on
operating profit from a stronger US dollar was largely offset by approximately $15 million lower
manufacturing and selling, general and administrative costs during the current period as a result
of cost reduction initiatives, including restructuring and integration activities in connection
with the Arrow acquisition, and lower expenses related to the remediation of FDA regulatory issues.
30
Medical Segment operating profit increased 5% from $141.6 million during the first six months
of 2008 to $148.8 million during the first six months of 2009. The negative impact on operating
profit from slighty lower revenues and a stronger US dollar was largely offset by approximately $19
million of lower manufacturing and selling, general and administrative costs during the current
period as a result of cost reduction initiatives, including restructuring and integration
activities in connection with the Arrow acquisition, and lower expenses related to the remediation
of FDA regulatory issues. Also, a $7 million expense for fair value adjustment to inventory in the
first quarter and year to date 2008 related to inventory acquired in the Arrow acquisition, which
did not recur in 2009, had a favorable impact on the comparison of first quarter of 2009 operating
profit to the prior year period.
Aerospace
Aerospace Segment revenues declined 44% in the second quarter of 2009 to $37.0 million, from
$65.7 million in the same period last year and declined 39% for the first six months of 2009 to
$80.7 million, from $132.0 million in the same period of 2008. The current weakness in the commercial aviation sector has reduced the number of aftermarket cargo
system conversions, resulting in lower sales of wide body cargo handling systems. In addition,
market weakness has resulted in reduced sales to commercial airlines and freight carriers of wide
body cargo spare components and repairs and cargo containers and actuators. These reductions were the principal factors driving the 36% and 32% decline in core revenue during
the quarter and for the first six months, respectively.
Segment operating profit decreased 87% in the second quarter of 2009, from $7.7 million to
$1.0 million, and decreased 68% for the first six months of 2009, from $12.6 million to $4.1
million. This was principally due to the sharply lower sales volumes
across the product
lines noted above, including an unfavorable mix of lower margin systems sales compared with spares
and repairs. The decrease was partially offset by cost reduction initiatives that resulted in
operating cost reductions of approximately $2 million in the second quarter of 2009 and approximately $4
million for the first six months of 2009 compared to the same periods of 2008.
Commercial
Commercial Segment revenues declined approximately 25% in the second quarter of 2009 to $82.2
million, from $109.6 million in the same period last year, 18% of which is due to a decline in core
revenue. The decline in core revenue was principally a result of a decline in sales of marine
products to OEM manufacturers for the recreational boat market (9%) and lower volumes for alternate
fuel systems and rigging services (9%) while sales of spare parts in the Marine aftermarket were
flat with the same period of 2008. Weakness in global economic conditions continues to adversely
impact the markets served by our Commercial businesses.
Commercial Segment revenues declined approximately 21% in the first six months of 2009 to
$167.6 million, from $211.4 million in the same period last year, 16% of which is due to a decline
in core revenue. The decline in core revenue was principally a result of a decline in sales of
marine products to OEM manufacturers for the recreational boat market (13%) and lower volumes for
alternate fuel systems (4%).
During the second quarter of 2009, operating profit in the Commercial Segment decreased 66%,
from $9.5 million to $3.2 million principally due to the lower sales volumes of marine products to
OEM manufacturers for the recreational boat market, alternate fuel systems and rigging services,
higher warranty costs related to the truck auxiliary power unit products, and the sale of higher
cost inventory in the rigging services business which more than offset the impact from the
elimination of approximately $4 million of operating costs compared to the corresponding prior year
quarter.
For the first six months of 2009, Commercial Segment operating income decreased 36% from $12.3
million to $7.8 million principally due to the lower sales volumes of marine products to OEM
manufacturers for the recreational boat market and alternate fuel systems, higher warranty costs
related to the truck auxiliary power unit products, and higher cost inventory in the rigging
services business which more than offset the impact from the elimination of approximately $8
million of operating costs compared to the corresponding prior year period.
Liquidity and Capital Resources
Operating activities from continuing operations used net cash of approximately $19 million
during the first six months of 2009. Changes in our operating assets and liabilities, which
reduced cash by $152 million during the first six months of 2009, primarily reflects payment of
income taxes, decreases in accounts payable and accrued expenses and an increase in inventory
partly offset by a reduction in accounts receivable. The movement in income taxes payable and
deferred income taxes of $116 million during the first six months of 2009 reflects tax payments of
approximately $133 million which included approximately $97 million related to the sale of the ATI
Business. The decrease in accounts payable and accrued expenses of $41 million is primarily related
to a $26 million reduction in accounts payable and a $15 million decrease in accrued expenses
reflecting payment of 2008 incentive compensation and reductions in the integration and
restructuring accruals due primarily to payments for termination benefits and contract
terminations. The change in inventory reflects deferred orders for wide body cargo system
conversions in the aftermarket in the Aerospace Segment
coupled with inventory build-up in advance of planned manufacturing relocations in the Medical
Segment, partly offset by a decrease in the Commercial Segment reflecting the sale of a product
line in the Marine business in the first quarter of 2009. The change in accounts receivable is
largely attributable to lower sales in the Aerospace and Commercial Segments, partly offset by
changes in the European Medical business, where we have experienced a slightly slower paying
pattern from our customers. We believe the slower paying pattern is a result of the current
economic environment.
31
Our financing activities from continuing operations during the first six months of 2009
consisted primarily of payment of $240 million in long-term borrowings, which we funded from the
proceeds of the sale of the ATI Business to GE and payment of dividends of $27 million. Cash flows
provided by our investing activities from continuing operations during the first six months of 2009
consisted primarily of the proceeds from the sale of the ATI Business, offset principally by $15
million of capital expenditures.
We use an accounts receivable securitization program to gain access to enhanced credit markets
and reduce financing costs. As currently structured, accounts receivable of certain domestic
subsidiaries are sold on a non-recourse basis to a special purpose entity (SPE), which is a
bankruptcy-remote consolidated subsidiary of Teleflex Incorporated. This SPE then sells undivided
interests in those receivables to an asset backed commercial paper conduit. The conduit issues
notes secured by those interests and other assets to third party investors.
To the extent that cash consideration is received for the sale of undivided interests in the
receivables by the SPE to the conduit, it is accounted for as a sale in accordance with SFAS No.
140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of
Liabilities, as we have relinquished control of the receivables. Accordingly, undivided interests
in accounts receivable sold to the commercial paper conduit under these transactions are excluded
from accounts receivables, net in the condensed consolidated balance sheets. The interests for
which cash consideration is not received from the conduit are retained by the SPE and remain in
accounts receivable in the accompanying condensed consolidated balance sheets.
The interests in receivables sold and the interest in receivables retained by the SPE are
carried at face value, which is due to the short-term nature of our accounts receivable. The
special purpose entity has received cash consideration of $39.7 million and $39.7 million for the
interests in the accounts receivable it has sold to the commercial paper conduit at June 28, 2009
and December 31, 2008, respectively. No gain or loss is recorded upon sale as fee charges from the
commercial paper conduit are based upon a floating yield rate and the period the undivided
interests remain outstanding. Fee charges from the commercial paper conduit are accrued at the end
of each month. Should we default under the accounts receivable securitization program, the
commercial paper conduit is entitled to receive collections on receivables owned by the SPE in
satisfaction of the amount of cash consideration paid to the SPE to the commercial paper conduit.
The assets of the SPE are not available to satisfy the obligations of Teleflex or any of its other
subsidiaries.
On June 14, 2007, our Board of Directors authorized the repurchase of up to $300 million of
our outstanding common stock. Repurchases of our stock under the Board authorization may be made
from time to time in the open market and may include privately-negotiated transactions as market
conditions warrant and subject to regulatory considerations. The stock repurchase program has no
expiration date and the our ability to execute on the program will depend on, among other factors,
cash requirements for acquisitions, cash generation from operations, debt repayment obligations,
market conditions and regulatory requirements. In addition, our senior loan agreements impose
certain restrictions on our ability to repurchase shares in the event our consolidated leverage
ratio (described below) exceeds certain levels, which may further limit our ability to repurchase
shares under this Board authorization. Through June 28, 2009, no shares have been purchased under
this Board authorization.
The following table provides our net debt to total capital ratio:
|
|
|
|
|
|
|
|
|
|
|
June 28, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Net debt includes: |
|
|
|
|
|
|
|
|
Current borrowings |
|
$ |
5,736 |
|
|
$ |
108,853 |
|
Long-term borrowings |
|
|
1,299,686 |
|
|
|
1,437,538 |
|
|
|
|
|
|
|
|
Total debt |
|
|
1,305,422 |
|
|
|
1,546,391 |
|
Less: Cash and cash equivalents |
|
|
114,270 |
|
|
|
107,275 |
|
|
|
|
|
|
|
|
Net debt |
|
$ |
1,191,152 |
|
|
$ |
1,439,116 |
|
|
|
|
|
|
|
|
Total capital includes: |
|
|
|
|
|
|
|
|
Net debt |
|
$ |
1,191,152 |
|
|
$ |
1,439,116 |
|
Total common shareholders equity |
|
|
1,462,050 |
|
|
|
1,246,455 |
|
|
|
|
|
|
|
|
Total capital |
|
$ |
2,653,202 |
|
|
$ |
2,685,571 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent of net debt to total capital |
|
|
45 |
% |
|
|
54 |
% |
32
Our current borrowings decreased significantly during the first six months of 2009 because we
repaid $240 million of debt from the proceeds of the sale of the ATI Business. Of the $240 million
payment $153 million represented scheduled principal payments through June 30, 2010 on our term
loan.
Our senior credit agreement and senior note agreements, which we refer to as the senior loan
agreements, contain covenants that, among other things, limit or restrict our ability, and the
ability of our subsidiaries, to incur debt, create liens, consolidate, merge or dispose of certain
assets, make certain investments, engage in acquisitions, pay dividends on, repurchase or make
distributions in respect of capital stock and enter into swap agreements. These agreements also
require us to maintain a Consolidated Leverage Ratio (generally, Consolidated Total Indebtedness to
Consolidated EBITDA, each as defined in the senior credit agreement) and a Consolidated Interest
Coverage Ratio (generally, Consolidated EBITDA to Consolidated Interest Expense, each as defined in
the senior credit agreement) at specified levels as of the last day of any period of four
consecutive fiscal quarters ending on or nearest to the end of each calendar quarter, calculated
pursuant to the definitions and methodology set forth in the senior credit agreement. The
following table indicates the applicable ratios under the senior loan agreements and provides
actual ratios for prior periods.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Leverage |
|
|
Consolidated Interest |
|
|
|
Ratio |
|
|
Coverage Ratio |
|
|
|
Must be |
|
|
|
|
|
|
Must be |
|
|
|
|
Fiscal quarter ending on or nearest to |
|
less than |
|
|
Actual |
|
|
more than |
|
|
Actual |
|
December 31, 2007 |
|
|
4.75:1 |
|
|
|
3.80:1 |
|
|
|
3.00:1 |
|
|
|
3.46:1 |
|
March 31, 2008 |
|
|
4.75:1 |
|
|
|
3.84:1 |
|
|
|
3.00:1 |
|
|
|
3.51:1 |
|
June 30, 2008 |
|
|
4.75:1 |
|
|
|
3.71:1 |
|
|
|
3.00:1 |
|
|
|
3.58:1 |
|
September 30, 2008 |
|
|
4.75:1 |
|
|
|
3.43:1 |
|
|
|
3.00:1 |
|
|
|
3.78:1 |
|
December 31, 2008 |
|
|
4.00:1 |
|
|
|
3.29:1 |
|
|
|
3.50:1 |
|
|
|
4.04:1 |
|
March 31, 2009 |
|
|
4.00:1 |
|
|
|
3.13:1 |
|
|
|
3.50:1 |
|
|
|
4.16:1 |
|
June 30, 2009 |
|
|
4.00:1 |
|
|
|
3:19:1 |
|
|
|
3.50:1 |
|
|
|
4:37:1 |
|
September 30, 2009
and at all times thereafter |
|
|
3.50:1 |
|
|
|
|
|
|
|
3.50:1 |
|
|
|
|
|
As of June 28, 2009, the aggregate amount of debt maturing for each year is as follows
(dollars in millions):
|
|
|
|
|
2009 |
|
$ |
5.7 |
|
2010 |
|
|
51.2 |
|
2011 |
|
|
247.2 |
|
2012 |
|
|
769.7 |
|
2013 |
|
|
|
|
2014 and thereafter |
|
|
231.6 |
|
We believe that our cash flow from operations and our ability to access additional funds
through credit facilities will enable us to fund our operating requirements and capital
expenditures and meet debt obligations. As of June 28, 2009, we had no outstanding borrowings and
approximately $7 million in outstanding stand by letters of credit issued under our $400 million
revolving credit facility.
Potential Tax Legislation
President Obama and the U.S. Treasury Department proposed, on May 5, 2009, changing certain
tax rules for U.S. corporations doing business outside the United States. The proposed changes
would limit the ability of U.S. corporations to deduct expenses attributable to foreign earnings,
modify the foreign tax credit rules and further restrict the ability of U.S. corporations to
transfer funds between foreign subsidiaries without triggering U.S. income tax. It is unclear
whether these proposed tax reforms will be enacted or, if enacted, what the ultimate scope of the
reforms will be. Depending on their content, such reforms, if enacted, could have an adverse effect
on our future operating results.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no significant changes in market risk for the quarter ended June 28, 2009.
See the information set forth in Part II, Item 7A of the Companys Annual Report on Form 10-K for
the fiscal year ended December 31, 2008.
Item 4. Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
33
Our management, with the participation of our Chief Executive Officer and Chief Financial
Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the
period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief
Financial Officer concluded that our disclosure controls and procedures as of the end of the period
covered by this report are functioning effectively to provide reasonable assurance that the
information required to be disclosed by us in reports filed under the Securities Exchange Act of
1934 is (i) recorded, processed, summarized and reported within the time periods specified in the
SECs rules and forms and (ii) accumulated and communicated to our management, including the Chief
Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding
disclosure. A controls system cannot provide absolute assurance that the objectives of the
controls system are met, and no evaluation of controls can provide absolute assurance that all
control issues and instances of fraud, if any, within a company have been detected.
(b) Change in Internal Control over Financial Reporting
No change in our internal control over financial reporting occurred during our most recent
fiscal quarter that has materially affected, or is reasonably likely to materially affect, our
internal control over financial reporting.
34
PART II OTHER INFORMATION
Item 1. Legal Proceedings
On October 11, 2007, the Companys subsidiary, Arrow International, Inc. (Arrow), received a
corporate warning letter from the U.S. Food and Drug Administration (FDA). The letter cites three
site-specific warning letters issued by the FDA in 2005 and subsequent inspections performed from
June 2005 to February 2007 at Arrows facilities in the United States. The letter expresses
concerns with Arrows quality systems, including complaint handling, corrective and preventive
action, process and design validation, inspection and training procedures. It also advises that
Arrows corporate-wide program to evaluate, correct and prevent quality system issues has been
deficient. Limitations on pre-market approvals and certificates for foreign governments had
previously been imposed on Arrow based on prior inspections and the corporate warning letter did
not impose additional sanctions that are expected to have a material financial impact on the
Company.
In connection with its acquisition of Arrow, completed on October 1, 2007, the Company
developed an integration plan that included the commitment of significant resources to correct
these previously-identified regulatory issues and further improve overall quality systems. Senior
management officials from the Company have met with FDA representatives, and a comprehensive
written corrective action plan was presented to FDA in late 2007. The Company has completed
implementation of the corrective actions under the plan and is awaiting re-inspection by the FDA.
While the Company believes it has substantially remediated these issues through the corrective
actions taken to date, there can be no assurances that these issues have been resolved to the
satisfaction of the FDA. If the Companys remedial actions are not satisfactory to the FDA, the
Company may have to devote additional financial and human resources to its efforts, and the FDA may
take further regulatory actions against the Company, including, but not limited to, seizing its
product inventory, obtaining a court injunction against further marketing of the Companys
products, assessing civil monetary penalties or imposing a consent decree on us.
In addition, we are a party to various lawsuits and claims arising in the normal course of
business. These lawsuits and claims include actions involving product liability, intellectual
property, employment and environmental matters. Based on information currently available, advice
of counsel, established reserves and other resources, we do not believe that any such actions are
likely to be, individually or in the aggregate, material to our business, financial condition,
results of operations or liquidity. However, in the event of unexpected further developments, it is
possible that the ultimate resolution of these matters, or other similar matters, if unfavorable,
may be materially adverse to our business, financial condition, results of operations or liquidity.
Item 1A. Risk Factors
There have been no significant changes in risk factors for the quarter ended June 28, 2009.
See the information set forth in Part I, Item 1A of the Companys Annual Report on Form 10-K for
the fiscal year ended December 31, 2008.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Not applicable.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Submission of Matters to a Vote of Security Holders
At the Companys 2009 Annual Meeting of Stockholders held on May 1, 2009, the Companys
stockholders voted on:
the election of four directors of the Company to serve for a term of three years or until
their successors have been elected and qualified; and
a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Companys
independent registered public accounting firm for the 2009 fiscal year.
35
With respect to the election of directors, the Companys stockholders elected each of Jeffrey
P. Black, Sigismundus W.W. Lubsen, Stuart A. Randle and Harold L. Yoh III to the Companys Board of
Directors to serve a three-year term expiring in 2012. The number of votes cast for or withheld
with respect to each nominee is set forth below:
|
|
|
|
|
|
|
|
|
Name |
|
For |
|
|
Withheld |
|
Jeffrey P. Black |
|
|
33,843,966 |
|
|
|
1,399,517 |
|
Sigismundus W.W. Lubsen |
|
|
34,101,938 |
|
|
|
1,141,545 |
|
Stuart A. Randle |
|
|
34,434,753 |
|
|
|
808,730 |
|
Harold L. Yoh III |
|
|
34,533,444 |
|
|
|
710,039 |
|
The directors of the Company comprising the other two classes of the Board, who continued in
office following the meeting are Patricia C. Barron, Jeffrey A. Graves and James W. Zug, whose
terms expire in 2010, and George Babich, Jr., William R. Cook, Stephen K. Klasko and Benson F.
Smith, whose terms expire in 2011.
The Companys stockholders ratified the appointment of PricewaterhouseCoopers LLP as the
Companys independent registered public accounting firm for the 2009 fiscal year. The number of
votes cast for or against, the number of abstentions and the number of broker non-votes with
respect to the proposal are set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
For |
|
Against |
|
|
Abstain |
|
|
Broker Non-Votes |
|
35,067,471 |
|
|
139,196 |
|
|
|
36,818 |
|
|
|
|
|
Item 5. Other Information
Not applicable.
Item 6. Exhibits
The following exhibits are filed as part of this report:
|
|
|
|
|
Exhibit No. |
|
|
|
Description |
|
|
|
|
|
31.1
|
|
|
|
Certification of Chief Executive Officer pursuant to
Rule 13a-14(a) under the Securities Exchange Act of
1934. |
|
|
|
|
|
31.2
|
|
|
|
Certification of Chief Financial Officer pursuant to
Rule 13a-14(a) under the Securities Exchange Act of
1934. |
|
|
|
|
|
32.1
|
|
|
|
Certification of Chief Executive Officer pursuant to
Rule 13a-14(b) under the Securities Exchange Act of
1934. |
|
|
|
|
|
32.2
|
|
|
|
Certification of Chief Financial Officer, Pursuant to
Rule 13a-14(b) under the Securities Exchange Act of
1934. |
36
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
TELEFLEX INCORPORATED
|
|
|
By: |
/s/ Jeffrey P. Black
|
|
|
|
Jeffrey P. Black |
|
|
|
Chairman and Chief Executive Officer
(Principal Executive Officer) |
|
|
|
By: |
/s/ Kevin K. Gordon
|
|
|
|
Kevin K. Gordon |
|
|
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer) |
|
|
|
|
|
By: |
/s/ Charles E. Williams
|
|
|
|
Charles E. Williams |
|
|
|
Corporate Controller and Chief Accounting Officer
(Principal Accounting Officer) |
|
Dated: July 27, 2009
37
EXHIBIT INDEX
|
|
|
|
|
Exhibit No. |
|
|
|
Description |
|
|
|
|
|
31.1
|
|
|
|
Certification of Chief Executive Officer pursuant to
Rule 13a-14(a) under the Securities Exchange Act of
1934. |
|
|
|
|
|
31.2
|
|
|
|
Certification of Chief Financial Officer pursuant to
Rule 13a-14(a) under the Securities Exchange Act of
1934. |
|
|
|
|
|
32.1
|
|
|
|
Certification of Chief Executive Officer pursuant to
Rule 13a-14(b) under the Securities Exchange Act of
1934. |
|
|
|
|
|
32.2
|
|
|
|
Certification of Chief Financial Officer, Pursuant to
Rule 13a-14(b) under the Securities Exchange Act of
1934. |
38